<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="fa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">fa</book-part-id>
      <title-group>
        <title>Fanconi Anemia</title>
        <alt-title alt-title-type="alt-title">Synonym: Fanconi Pancytopenia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mehta</surname>
            <given-names>Parinda A</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Associate Professor, Division of Bone Marrow Transplantation and Immune Deficiency<break/>Cincinnati Children's Hospital Medical Center<break/>Cincinnati, Ohio</aff>
          <email>parinda.mehta@cchmc.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tolar</surname>
            <given-names>Jakub</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Division of Blood and Marrow Transplantation<break/>Stem Cell Institute<break/>University of Minnesota<break/>Minneapolis, Minnesota</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>14</day>
          <month>2</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>22</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>23</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="tfap" document-type="chapter">Familial Transthyretin Amyloidosis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="fahn" document-type="chapter">Fatty Acid Hydroxylase-Associated Neurodegeneration</related-object>
      <abstract id="fa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors &#x02013; particularly of the head and neck, skin, gastrointestinal tract, and genitourinary tract &#x02013; are more common in individuals with FA.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of FA is established in a proband with increased chromosome breakage and radial forms on cytogenetic testing of lymphocytes with diepoxybutane (DEB) and mitomycin C (MMC). The diagnosis is confirmed by identification of one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Biallelic pathogenic variants in one of the 18 genes known to cause autosomal recessive FA</p>
            </list-item>
            <list-item>
              <p>A heterozygous pathogenic variant in <italic toggle="yes">RAD51</italic>, known to cause autosomal dominant FA</p>
            </list-item>
            <list-item>
              <p>A hemizygous pathogenic variant in <italic toggle="yes">FANCB</italic>, known to cause X-linked FA</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Administration of oral androgens (e.g., oxymetholone) improves blood counts (red cell and platelets) in approximately 50% of individuals with FA; administration of G-CSF improves the neutrophil count in some; hematopoietic stem cell transplantation (HSCT) is the only curative therapy for the hematologic manifestations of FA, but the high risk for solid tumors remains and may even be increased in those undergoing HSCT. All these treatments have potential significant toxicity. Early detection and surgical removal remains the mainstay of therapy for solid tumors.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Human papilloma virus (HPV) vaccination to reduce the risk of gynecologic cancer in females, and possibly reduce the risk of oral cancer in all individuals.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> T-cell depletion of the donor graft to minimize the risk of graft vs host disease; conditioning regimen without radiation prior to HSCT to reduce the risk of subsequent solid tumors.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual evaluation with a multidisciplinary team including an endocrinologist; monitoring for evidence of bone marrow failure (regular blood counts; at least annual bone marrow aspirate/biopsy to evaluate morphology, cellularity, and cytogenetics); for those receiving androgen therapy, monitoring liver function tests and regular ultrasound examination of the liver; monitoring for solid tumors (oropharyngeal and gynecologic examinations).</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Transfusions of red cells or platelets for persons who are candidates for HSCT; family members as blood donors if HSCT is being considered; blood products that are not filtered (leukodepleted) or irradiated; toxic agents that have been implicated in tumorigenesis; unsafe sex practices, which increase the risk of HPV-associated malignancy; radiographic studies solely for the purpose of surveillance (i.e., in the absence of clinical indications).</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> DEB/MMC testing or molecular genetic testing (if the family-specific pathogenic variants are known) of all sibs of a proband for early diagnosis, treatment, and monitoring for physical abnormalities, bone marrow failure, and related cancers.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Fanconi anemia (FA) can be inherited in an autosomal recessive manner, an autosomal dominant manner (<italic toggle="yes">RAD51</italic>-related FA), or an X-linked manner (<italic toggle="yes">FANCB</italic>-related FA).</p>
          <p><italic toggle="yes">Autosomal recessive FA:</italic> Each sib of an affected individual has a 25% chance of inheriting both pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being a carrier, and a 25% chance of inheriting both normal alleles and not being a carrier. Carriers (heterozygotes) for autosomal recessive FA are asymptomatic.</p>
          <p><italic toggle="yes">Autosomal dominant FA:</italic> Given that all affected individuals with <italic toggle="yes">RAD51</italic>-related FA reported to date have the disorder as a result of a <italic toggle="yes">de novo RAD51</italic> pathogenic variant, the risk to other family members is presumed to be low.</p>
          <p><italic toggle="yes">X-linked FA:</italic> For carrier females the chance of transmitting the pathogenic variant in each pregnancy is 50%; males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will usually not be affected.</p>
          <p>Carrier testing for at-risk relatives (for autosomal recessive and X-linked FA) and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="fa.Diagnosis">
        <title>Diagnosis</title>
        <p>Recommendations for diagnosis were agreed upon at a 2013 consensus conference (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://fanconi.org/index.php/publications/guidelines_for_diagnosis_and_management">Fanconi Anemia: Guidelines for Diagnosis and Management</ext-link>).</p>
        <sec id="fa.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Fanconi anemia (FA) <bold>should be suspected</bold> in individuals with the following clinical and laboratory features.</p>
          <p><bold>Physical features</bold> (in ~75% of affected persons)</p>
          <list list-type="bullet">
            <list-item>
              <p>Prenatal and/or postnatal short stature</p>
            </list-item>
            <list-item>
              <p>Abnormal skin pigmentation (e.g., caf&#x000e9; au lait macules, hypopigmentation)</p>
            </list-item>
            <list-item>
              <p>Skeletal malformations (e.g., hypoplastic thumb, hypoplastic radius)</p>
            </list-item>
            <list-item>
              <p>Microcephaly</p>
            </list-item>
            <list-item>
              <p>Ophthalmic anomalies</p>
            </list-item>
            <list-item>
              <p>Genitourinary tract anomalies</p>
            </list-item>
          </list>
          <p>
            <bold>Laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Macrocytosis</p>
            </list-item>
            <list-item>
              <p>Increased fetal hemoglobin (often precedes anemia)</p>
            </list-item>
            <list-item>
              <p>Cytopenia (especially thrombocytopenia, leukopenia and neutropenia)</p>
            </list-item>
          </list>
          <p>
            <bold>Pathology findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Progressive bone marrow failure</p>
            </list-item>
            <list-item>
              <p>Adult-onset aplastic anemia</p>
            </list-item>
            <list-item>
              <p>Myelodysplastic syndrome (MDS)</p>
            </list-item>
            <list-item>
              <p>Acute myelogenous leukemia (AML)</p>
            </list-item>
            <list-item>
              <p>Early-onset solid tumors (e.g., squamous cell carcinomas of the head and neck, esophagus, and vulva; cervical cancer; and liver tumors)</p>
            </list-item>
            <list-item>
              <p>Inordinate toxicities from chemotherapy or radiation</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of FA <bold>is established</bold> in a proband with the following findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Increased chromosome breakage and radial forms on cytogenetic testing of lymphocytes with diepoxybutane (DEB) and mitomycin C (MMC)</p>
            </list-item>
            <list-item>
              <p>Note: (1) The background rate of chromosome breakage in control chromosomes is more variable with MMC; thus, some centers use DEB while other centers use both DEB and MMC. (2) If results of lymphocyte testing are normal or inconclusive and mosaicism is suspected, testing can be performed on an alternative cell type, such as skin fibroblasts. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://fanconi.org/index.php/publications/guidelines_for_diagnosis_and_management">Fanconi Anemia: Guidelines for Diagnosis and Management</ext-link>.</p>
            </list-item>
            <list-item>
              <p>Identification of biallelic pathogenic variants in one of the 18 genes known to cause autosomal recessive FA, or a heterozygous pathogenic variant in <italic toggle="yes">RAD51</italic> known to cause autosomal dominant FA, or a hemizygous pathogenic variant in <italic toggle="yes">FANCB</italic>, known to cause X-linked FA (see <xref ref-type="table" rid="fa.T.molecular_genetics_of_fanconi_anemi">Table 1</xref>)</p>
            </list-item>
          </list>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">FANCA</italic> can be performed first, and followed by gene-targeted <italic toggle="yes">FANCA</italic> deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes the genes in <xref ref-type="table" rid="fa.T.molecular_genetics_of_fanconi_anemi">Table 1a</xref> and <xref ref-type="table" rid="fa.T.molecular_genetics_of_fanconi_anemi_1">Table 1b</xref> and other genes of interest (see <xref ref-type="sec" rid="fa.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered next if single-gene testing does not identify a <italic toggle="yes">FANCA</italic> pathogenic variant. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of Fanconi anemia. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="fa.T.molecular_genetics_of_fanconi_anemi" orientation="portrait" position="anchor">
            <label>Table 1a. </label>
            <caption>
              <p>Molecular Genetics of Fanconi Anemia: Most Common Genetic Causes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2">Complementation Group&#x000a0;<sup>3</sup></th>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3">% of FA Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>4</sup></th>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>5</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4" id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></th>
                  <th headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4" id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>7</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BRCA2</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-D1</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~3%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BRIP1</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-J</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~2%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCA</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-A</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">60%-70%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~60%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;20 deletion/duplication variants reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCB</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-B</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~2%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication variants reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCC</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-C</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~14%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Several deletion/duplication variants reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCD2</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-D2</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~3%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple deletion/duplication variants reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCE</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-E</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~3%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCF</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-F</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~2%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication variants reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCG</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-G</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~10%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCI</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-I</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~1%</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_4 hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication variant reported; see <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">HGMD</related-object></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Pathogenic variants of any one of the genes included in this table account for &#x0003e;1% of FA</p>
              </fn>
              <fn id="fa.TF.1a.1">
                <label>1. </label>
                <p>Genes are listed in alphabetic order.</p>
              </fn>
              <fn id="fa.TF.1a.2">
                <label>2. </label>
                <p>See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="fa.TF.1a.3">
                <label>3. </label>
                <p>Prior to identification of the genes, complementation groups were defined based on somatic cell-based methods. While complementation analysis testing has been supplanted by multi-gene panels; this terminology continues to be used in some contexts.</p>
              </fn>
              <fn id="fa.TF.1a.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="fa.REF.shimamura.2010.101">Shimamura &#x00026; Alter [2010]</xref>
                </p>
              </fn>
              <fn id="fa.TF.1a.5">
                <label>5. </label>
                <p>See <xref ref-type="sec" rid="fa.Molecular_Genetics">Molecular Genetics</xref> for information on pathogenic variants detected.</p>
              </fn>
              <fn id="fa.TF.1a.6">
                <label>6. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="fa.TF.1a.7">
                <label>7. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="fa.T.molecular_genetics_of_fanconi_anemi_1" orientation="portrait" position="anchor">
            <label>Table 1b. </label>
            <caption>
              <p>Molecular Genetics of Fanconi Anemia: Less Common Genetic Causes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></th>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Complementation Group&#x000a0;<sup>4</sup></th>
                  <th id="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Comment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC4</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-Q</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2 individuals w/FA &#x00026; biallelic <italic toggle="yes">ERCC4</italic> pathogenic variants reported [<xref ref-type="bibr" rid="fa.REF.bogliolo.2013.800">Bogliolo et al 2013</xref>]; functional studies of <italic toggle="yes">ERCC4</italic> missense variants reported by <xref ref-type="bibr" rid="fa.REF.osorio.2013.1615">Osorio et al [2013]</xref>.</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCL</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-L</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13 <italic toggle="yes">FANCL</italic> pathogenic variants reported [<xref ref-type="bibr" rid="fa.REF.chandrasekharappa.2013.e138">Chandrasekharappa et al 2013</xref>, <xref ref-type="bibr" rid="fa.REF.nicchia.2015.1003">Nicchia et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.vetro.2015.562">Vetro et al 2015</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">FANCM</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-M</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Assignment of a formal complementation group for persons w/<italic toggle="yes">FANCM</italic> pathogenic variants still controversial as only 1 reference family/cell line has been identified &#x00026; that cell line has been determined to have biallelic pathogenic variants in both <italic toggle="yes">FANCA</italic> &#x00026; <italic toggle="yes">FANCM</italic>. Of note, under experimental conditions specific knockdown of <italic toggle="yes">FANCM</italic> alone results in an FA phenotype [<xref ref-type="bibr" rid="fa.REF.singh.2009.174">Singh et al 2009</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MAD2L2</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-V</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1 individual w/homozygous pathogenic variants reported [<xref ref-type="bibr" rid="fa.REF.bluteau.2016.3580">Bluteau et al 2016</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PALB2</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-N</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">14 <italic toggle="yes">PALB2</italic> pathogenic variants reported including a deletion of exons 1-10 [<xref ref-type="bibr" rid="fa.REF.reid.2007.162">Reid et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.xia.2007.159">Xia et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.byrd.2016.e1005945">Byrd et al 2016</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">RAD51</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-R</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2 individuals w/features of FA &#x00026; a <italic toggle="yes">de novo</italic>
<italic toggle="yes">RAD51</italic> pathogenic variant reported [<xref ref-type="bibr" rid="fa.REF.ameziane.2015.8829">Ameziane et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.wang.2015.478">Wang et al 2015</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">RAD51C</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-O</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Assignment of a formal complementation group for persons w/<italic toggle="yes">RAD51C</italic> pathogenic variants still controversial as only 1 reference consanguineous family identified [<xref ref-type="bibr" rid="fa.REF.vaz.2010.406">Vaz et al 2010</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SLX4</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-P</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Assignment of a formal complementation group for persons with <italic toggle="yes">SLX4</italic> pathogenic variants still controversial as only a handful of reference families have been identified &#x00026; <italic toggle="yes">SLX4</italic> biology falls outside previously characterized FA proteins [<xref ref-type="bibr" rid="fa.REF.kim.2011.142">Kim et al 2011</xref>, <xref ref-type="bibr" rid="fa.REF.stoepker.2011.138">Stoepker et al 2011</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">UBE2T</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-T</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1 individual w/biallelic <italic toggle="yes">UBE2T</italic> pathogenic variants including a large paternal deletion &#x00026; a maternal duplication reported [<xref ref-type="bibr" rid="fa.REF.rickman.2015.35">Rickman et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.virts.2015.5093">Virts et al 2015</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XRCC2</italic>
                  </td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">FA-U</td>
                  <td headers="hd_h_fa.T.molecular_genetics_of_fanconi_anemi_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1 indivdiual w/homozygous pathogenic variants reported [<xref ref-type="bibr" rid="fa.REF.park.2016.672">Park et al 2016</xref>]</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., &#x0003c;1% of FA)</p>
              </fn>
              <fn id="fa.TF.1b.1">
                <label>1. </label>
                <p>Genes are listed in alphabetic order.</p>
              </fn>
              <fn id="fa.TF.1b.2">
                <label>2. </label>
                <p>See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="fa.TF.1b.3">
                <label>3. </label>
                <p>Genes are not described in detail in <xref ref-type="sec" rid="fa.Molecular_Genetics">Molecular Genetics</xref> but may be included <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="fa-less_common_genes.pdf" content-type="local-data">here</inline-supplementary-material> (pdf).</p>
              </fn>
              <fn id="fa.TF.1b.4">
                <label>4. </label>
                <p>Prior to identification of the genes, complementation groups were defined based on somatic cell-based methods this terminology continues to be used in some contexts.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="fa.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="fa.Clinical_Description">
          <title>Clinical Description</title>
          <p>The primary clinical features of Fanconi anemia (FA) include physical features, progressive bone marrow failure manifest as pancytopenia, and cancer susceptibility; however, some individuals with FA have neither physical abnormalities nor bone marrow failure.</p>
          <p><bold>Physical features</bold> occur in approximately 75% of individuals with FA.</p>
          <list list-type="bullet">
            <list-item>
              <p>Growth deficiency: prenatal and/or postnatal short stature, low birth weight</p>
            </list-item>
            <list-item>
              <p>Abnormal skin pigmentation (40%): generalized hyperpigmentation; caf&#x000e9; au lait macules, hypopigmentation</p>
            </list-item>
            <list-item>
              <p>Skeletal malformations of upper limbs, unilateral or bilateral (35%):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Thumbs (35%): absent, hypoplastic, bifid, duplicated, triphalangeal, long, proximally placed</p>
                </list-item>
                <list-item>
                  <p>Radii (7%): absent or hypoplastic (only with abnormal thumbs), absent or weak pulse</p>
                </list-item>
                <list-item>
                  <p>Hands (5%): flat thenar eminence, absent first metacarpal, clinodactyly, polydactyly</p>
                </list-item>
                <list-item>
                  <p>Ulnae (1%): dysplastic, short</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Skeletal malformations of lower limbs (5%)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Syndactyly, abnormal toes, club feet</p>
                </list-item>
                <list-item>
                  <p>Congenital hip dislocation</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Microcephaly (20%)</p>
            </list-item>
            <list-item>
              <p>Ophthalmic (20%): microphthalmia, cataracts, astigmatism, strabismus, epicanthal folds, hypotelorism, hypertelorism, ptosis</p>
            </list-item>
            <list-item>
              <p>Genitourinary tract anomalies:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Renal (20%): horseshoe, ectopic, pelvic, hypoplastic, dysplastic, or absent kidney; hydronephrosis or hydroureter</p>
                </list-item>
                <list-item>
                  <p>Males (25%). Hypospadias, micropenis, cryptorchidism, anorchia, hypo- or azoospermia, reduced fertility</p>
                </list-item>
                <list-item>
                  <p>Females (2%). bicornuate or uterus malposition, small ovaries</p>
                  <p>Note: Pregnancy is possible in females, whether or not they have undergone hematopoietic stem cell transplantation.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Endocrine: hypothyroidism, glucose/insulin abnormalities</p>
            </list-item>
            <list-item>
              <p>Hearing loss, usually conductive secondary to middle ear bony anomalies; abnormal ear shape: dysplastic, narrow ear canal, abnormal pinna (10%)</p>
            </list-item>
            <list-item>
              <p>Congenital heart defect (6%): patent ductus arteriosus, atrial septal defect, ventricular septal defect, coarctation of the aorta, truncus arteriosus, situs inversus</p>
            </list-item>
            <list-item>
              <p>Gastrointestinal (5%): esophageal, duodenal, or jejunal atresia, imperforate anus, tracheoesophageal fistula, annular pancreas, malrotation</p>
            </list-item>
            <list-item>
              <p>Central nervous system (3%): small pituitary, pituitary stalk interruption syndrome, absent corpus callosum, cerebellar hypoplasia, hydrocephalus, dilated ventricles</p>
            </list-item>
            <list-item>
              <p>Other</p>
              <list list-type="bullet">
                <list-item>
                  <p>Facial features (2%): triangular, micrognathia, mid-face hypoplasia</p>
                </list-item>
                <list-item>
                  <p>Spine anomalies (2%): spina bifida, scoliosis, hemivertebrae, rib anomalies, coccygeal aplasia</p>
                </list-item>
                <list-item>
                  <p>Neck anomalies (1%): Sprengel deformity, Klippel-Feil anomaly, short or webbed neck, low hairline</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: Percentages are calculated from 2000 individuals reported in the literature from 1927 to 2009. Frequencies are approximate, since many reports did not mention physical descriptions.</p>
          <p><bold>Developmental delay</bold> and/or intellectual disability (10%)</p>
          <p><bold>Bone marrow failure.</bold> The age of onset is highly variable, even among sibs. An analysis of 754 individuals with pathogenic variants in <italic toggle="yes">FANCA</italic>, <italic toggle="yes">FANCC</italic>, and <italic toggle="yes">FANCG</italic> identified an average age of onset of 7.6 years. Rarely, bone marrow failure can present in infants and small children [<xref ref-type="bibr" rid="fa.REF.shimamura.2010.101">Shimamura &#x00026; Alter 2010</xref>]. The risk of developing any hematologic abnormality is 90% by age 40 years [<xref ref-type="bibr" rid="fa.REF.kutler.2003.1249">Kutler et al 2003</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Thrombocytopenia or leukopenia usually precede anemia. These are commonly associated with macrocytosis and elevated fetal hemoglobin.</p>
            </list-item>
            <list-item>
              <p>Pancytopenia generally worsens over time.</p>
            </list-item>
            <list-item>
              <p>Sweet syndrome (neutrophilic skin infiltration) was associated with progression of hematologic disease in six out of seven individuals with FA [<xref ref-type="bibr" rid="fa.REF.giulino.2011.278">Giulino et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>The severity of bone marrow failure can be classified by the degree of cytopenia(s) (<xref ref-type="table" rid="fa.T.selected_fanca_pathogenic_variants">Table 3</xref>). Importantly, to meet these criteria for marrow failure, the cytopenias must be persistent and unexplained by other causes.</p>
            </list-item>
          </list>
          <table-wrap id="fa.T.severity_of_bone_marrow_failure_in" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Severity of Bone Marrow Failure in Fanconi Anemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                  <th id="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mild</th>
                  <th id="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Moderate</th>
                  <th id="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Severe</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Absolute neutrophil count (ANC)</bold>
                  </td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1,500/mm<sup>3</sup></td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1,000/mm<sup>3</sup></td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;500/mm<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Platelet count</bold>
                  </td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">150,000-50,000/mm<sup>3</sup></td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;50,000/mm<sup>3</sup></td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;30,000/mm<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hemoglobin (Hb) level</bold>
                  </td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02265;8 g/dL</td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;8 g/dL</td>
                  <td headers="hd_h_fa.T.severity_of_bone_marrow_failure_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;8 g/dL</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p><bold>Cancer susceptibility.</bold> The relative risk for acute myelogenous leukemia (AML) is increased approximately 500-fold [<xref ref-type="bibr" rid="fa.REF.rosenberg.2008.511">Rosenberg et al 2008</xref>, <xref ref-type="bibr" rid="fa.REF.alter.2010.179">Alter et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.tamary.2010.1300">Tamary et al 2010</xref>]. In a competing risk analysis of the combined cohorts, the cumulative incidence of AML was 13% by age 50 years, with most individuals diagnosed between ages 15 and 35 years.</p>
          <p>An increased risk of developing myelodysplastic syndrome (MDS)/AML is associated with monosomy 7 and most 7q deletions. Clonal amplifications of chromosome 3q26-q29 were reported in association with an increased risk of progression to MDS/AML [<xref ref-type="bibr" rid="fa.REF.neitzel.2007">Neitzel et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.mehta.2010.180">Mehta et al 2010</xref>].</p>
          <p><bold>Solid tumors</bold> may be the first manifestation of FA in individuals who have no birth defects and have not experienced bone marrow failure.</p>
          <list list-type="bullet">
            <list-item>
              <p>Head and neck squamous cell carcinomas (HNSCCs) are the most common solid tumor in individuals with FA. The incidence is 500- to 700-fold higher than in the general population. The HNSCCs in FA show distinct differences compared to HNSCCs seen in the general population. HNSCCs:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Occur at an earlier age (20-40 years) than in the general population;</p>
                </list-item>
                <list-item>
                  <p>Are most commonly in the the oral cavity (e.g., tongue);</p>
                </list-item>
                <list-item>
                  <p>Present at an advanced stage;</p>
                </list-item>
                <list-item>
                  <p>Respond poorly to therapy.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Individuals with FA are at increased risk for second primary cancers in the skin and genitourinary tract. The pattern of second primaries resembles that observed in HPV-associated HNSCC in the general population [<xref ref-type="bibr" rid="fa.REF.morris.2011.739">Morris et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>Individuals with FA receiving androgen treatment for bone marrow failure are also at increased risk for liver tumors.</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p><bold><italic toggle="yes">BRCA2</italic>.</bold> Biallelic pathogenic variants in <italic toggle="yes">BRCA2</italic> are associated with early-onset acute leukemia and solid tumors [<xref ref-type="bibr" rid="fa.REF.hirsch.2004.2554">Hirsch et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.wagner.2004.3226">Wagner et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.myers.2012.462">Myers et al 2012</xref>]. The cumulative probability of any malignancy was 97% by age six years, including AML, medulloblastoma, and Wilms tumor [<xref ref-type="bibr" rid="fa.REF.alter.2007.1">Alter et al 2007</xref>].</p>
          <p><bold><italic toggle="yes">FANCG</italic>.</bold> Pathogenic variants in <italic toggle="yes">FANCG</italic> may be associated with severe marrow failure and a higher incidence of leukemia compared to <italic toggle="yes">FANCC</italic> [<xref ref-type="bibr" rid="fa.REF.faivre.2000.4064">Faivre et al 2000</xref>].</p>
          <p><bold><italic toggle="yes">PALB2.</italic></bold> Solid tumors (e.g., medulloblastoma, Wilms tumor) are associated with <italic toggle="yes">PALB2</italic> pathogenic variants [<xref ref-type="bibr" rid="fa.REF.reid.2007.162">Reid et al 2007</xref>].</p>
        </sec>
        <sec id="fa.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The clinical spectrum of FA remains heterogenous. There are no clearcut genotype-phenotype correlations [<xref ref-type="bibr" rid="fa.REF.neveling.2009.73">Neveling et al 2009</xref>]. In general, null variants lead to a more severe phenotype (e.g., congenital anomalies, early-onset bone marrow failure, and MDS/AML) than hypomorphic variants.</p>
          <p><bold><italic toggle="yes">BRCA2</italic>.</bold> All persons with an IVS7 pathogenic variant in <italic toggle="yes">BRCA2</italic> developed AML by age three years; those with other <italic toggle="yes">BRCA2</italic> pathogenic variants who developed AML did so by age six years [<xref ref-type="bibr" rid="fa.REF.alter.2006.446">Alter 2006</xref>].</p>
          <p><bold><italic toggle="yes">FANCA</italic>.</bold> Individuals who are homozygous for null pathogenic variants in <italic toggle="yes">FANCA</italic> may have earlier onset of anemia and higher incidence of leukemia than individuals with pathogenic variants that permit production of an abnormal FANCA protein [<xref ref-type="bibr" rid="fa.REF.faivre.2000.4064">Faivre et al 2000</xref>].</p>
          <p>
            <bold>
              <italic toggle="yes">FANCC</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="table" rid="fa.T.selected_fancc_pathogenic_variants">c.456+4A&#x0003e;T</xref>, <xref ref-type="table" rid="fa.T.selected_fancc_pathogenic_variants">p.Arg548Ter</xref>, and <xref ref-type="table" rid="fa.T.selected_fancc_pathogenic_variants">p.Leu554Pro</xref> are associated with earlier onset of hematologic abnormalities and more severe congenital anomalies than other pathogenic variants, such as del22G [<xref ref-type="bibr" rid="fa.REF.faivre.2005.55">Faivre et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="fa.T.selected_fancc_pathogenic_variants">p.Asp23IlefsTer23</xref> and <xref ref-type="table" rid="fa.T.selected_fancc_pathogenic_variants">p.Gln13Ter</xref> are associated with a lower risk for congenital anomalies and later progression to bone marrow failure [<xref ref-type="bibr" rid="fa.REF.yamashita.1996.4424">Yamashita et al 1996</xref>, <xref ref-type="bibr" rid="fa.REF.gillio.1997.105">Gillio et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p>c.456+4A&#x0003e;T results in a milder phenotype in Japanese individuals than in Ashkenazi Jewish individuals [<xref ref-type="bibr" rid="fa.REF.futaki.2000.1493">Futaki et al 2000</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Prevalence">
          <title>Prevalence</title>
          <p>Fanconi anemia (FA) is the most common genetic cause of aplastic anemia and one of the most common genetic causes of hematologic malignancy.</p>
          <p>The ratio of males to females is 1.2:1 (p &#x0003c;0.001 vs expected 1.00).</p>
          <p><xref ref-type="bibr" rid="fa.REF.rosenberg.2011.1877">Rosenberg et al [2011]</xref> showed higher carrier rates for FA than previously reported. Carrier frequency was 1:181 in North Americans and 1:93 in Israel. Specific populations have founder variants with increased carrier frequencies (&#x0003c;1:100), including Ashkenazi Jews (<italic toggle="yes">FANCC</italic>, <italic toggle="yes">BRCA2</italic>), northern Europeans (<italic toggle="yes">FANCC</italic>), Afrikaners (<italic toggle="yes">FANCA</italic>), sub-Saharan Blacks (<italic toggle="yes">FANCG</italic>), Spanish Gypsies (<italic toggle="yes">FANCA</italic>), and others.</p>
        </sec>
      </sec>
      <sec id="fa.Genetically_Related_Allelic_Disorders">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Hereditary breast and ovarian cancer is associated with heterozygous pathogenic variants in <italic toggle="yes">BRCA2</italic>.</p>
        <p>Heterozygous pathogenic variants in <italic toggle="yes">BRIP1</italic> and <italic toggle="yes">PALB2</italic> have been implicated in breast cancer and ovarian cancer predisposition [<xref ref-type="bibr" rid="fa.REF.seal.2006.1239">Seal et al 2006</xref>, <xref ref-type="bibr" rid="fa.REF.rahman.2007.165">Rahman et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.rafnar.2011.1104">Rafnar et al 2011</xref>].</p>
        <p>Heterozygous pathogenic variants in <italic toggle="yes">PALB2</italic> have been implicated in pancreatic cancer predisposition [<xref ref-type="bibr" rid="fa.REF.jones.2009.217">Jones et al 2009</xref>].</p>
        <p>Biallelic pathogenic variants in <italic toggle="yes">ERCC4</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="xp" document-type="chapter">xeroderma pigmentosum</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cockayne" document-type="chapter">Cockayne syndrome</related-object>, and XFE progeroid syndrome.</p>
      </sec>
      <sec id="fa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Cells derived from individuals with other chromosome breakage syndromes, such as <related-object link-type="booklink" source-id="gene" document-id="bloom" document-type="chapter">Bloom syndrome</related-object> or <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object>, may also exhibit high rates of spontaneous chromosome breakage; however, only FA cells exhibit increased chromosome breakage in response to diepoxybutane (DEB).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="nijmegen" document-type="chapter">Nijmegen breakage syndrome</related-object> (NBS), characterized by short stature, progressive microcephaly with loss of cognitive skills, premature ovarian failure in females, recurrent sinopulmonary infections, and an increased risk for cancer (particularly lymphoma), may also manifest increased chromosome breakage with mitomycin C (MMC) [<xref ref-type="bibr" rid="fa.REF.chrzanowska.2012.13">Chrzanowska et al 2012</xref>]. Inheritance is autosomal recessive. NBS may be distinguished from FA by <italic toggle="yes">NBN</italic> molecular genetic testing, which identifies pathogenic variants in almost 100% of individuals with NBS.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="microcephaly" document-type="chapter">Seckel syndrome</related-object>, characterized by growth retardation, microcephaly with intellectual disability, and a characteristic 'bird-headed' facial appearance, may also show increased chromosome breakage with DNA cross-linking agents (MMC, DEB) [<xref ref-type="bibr" rid="fa.REF.andreassen.2004.1958">Andreassen et al 2004</xref>]. Some individuals with Seckel syndrome also develop pancytopenia and/or AML. Inheritance is autosomal recessive. Biallelic pathogenic variants in <italic toggle="yes">ATR</italic>, <italic toggle="yes">NIN</italic>, <italic toggle="yes">ATRIP</italic>, <italic toggle="yes">RBBP8</italic>, <italic toggle="yes">CEP152</italic>, <italic toggle="yes">CENPJ</italic>, and <italic toggle="yes">CEP63</italic> are causative.</p>
        <p>Other disorders including <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis 1</related-object> (which could be considered because of caf&#x000e9; au lait macules), <related-object link-type="booklink" source-id="gene" document-id="tar" document-type="chapter">TAR syndrome</related-object> (thrombocytopenia with absent radii), and VACTERL association (radial ray defects) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/192350">192350</ext-link>) can be distinguished from FA by testing for chromosome breakage with DEB and MMC.</p>
      </sec>
      <sec id="fa.Management">
        <title>Management</title>
        <sec id="fa.Evaluations_Following_Initial_Diagnos">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and management requirements in an individual diagnosed with Fanconi anemia (FA), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation by a hematologist, to include complete blood count, fetal hemoglobin, full blood typing, blood chemistries (assessing liver, kidney, and iron status), and bone marrow aspirate for cell morphology, FISH and cytogenetics, as well as biopsy for cellularity</p>
              <p>Note: The bone marrow of individuals with FA can exhibit signs of dysplasia, such as nuclear/cytoplasmic dys-synchrony, hypo-lobulated megakaryocytes, and bi-nucleated erythroid cells. These features must be distinguished from true forms of MDS by a hematopathologist experienced in the evaluation of MDS in individuals with FA.</p>
            </list-item>
            <list-item>
              <p>HLA typing of the affected individual, sibs, and parents for consideration of hematopoietic stem cell transplantation</p>
            </list-item>
            <list-item>
              <p>Examination by an ophthalmologist</p>
            </list-item>
            <list-item>
              <p>Ultrasound examination of the kidneys and urinary tract</p>
            </list-item>
            <list-item>
              <p>Formal hearing evaluation</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>Referral to an endocrinologist</p>
            </list-item>
            <list-item>
              <p>Developmental assessment (particularly important for toddlers and school-age children)</p>
            </list-item>
            <list-item>
              <p>Referrals as indicated to an otolaryngologist, hand surgeon, gastroenterologist, gynecologist, and urologist</p>
            </list-item>
            <list-item>
              <p>Evaluation by a clinical geneticist and genetic counseling</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Recommendations for treatment were agreed upon at a 2014 consensus conference (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://fanconi.org/images/uploads/other/FA_Guidelines_4th_Edition_Revised_Names_in_Appendix.pdf">full text</ext-link>).</p>
          <p><bold>Androgens</bold> improve (at least transiently) the red cell and platelet counts in approximately 50% of individuals. Androgen therapy can be considered when the hemoglobin drops below 8 g/dL or the platelet count falls below 30,000/mm<sup>3</sup> ('severe' &#x02013; see <xref ref-type="table" rid="fa.T.severity_of_bone_marrow_failure_in">Table 2</xref>). Although only 10%-20% of individuals receiving continuous low-dose androgen therapy are long-term responders, this option can be particularly useful for individuals who do not have access to or are not ready for hematopoietic stem cell transplant (HSCT), or to individuals for whom of a suitable donor is not available.</p>
          <list list-type="bullet">
            <list-item>
              <p>Oxymetholone, given orally at a starting dose of 2 mg/kg/day, may be increased up to 5 mg/kg/day.</p>
            </list-item>
            <list-item>
              <p>Doses may be slowly tapered to the minimal effective dose with careful monitoring of the blood counts.</p>
            </list-item>
            <list-item>
              <p>Other synthetic androgens used in FA include stanazolol in Asia, and oxandrolone and danazol in North America.</p>
            </list-item>
          </list>
          <p>Side effects of androgen administration include virilization and liver toxicity such as elevated liver enzymes, cholestasis, peliosis hepatis (vascular lesion with multiple blood-filled cysts), and hepatic tumors. Individuals taking androgens should be monitored for liver tumors and undergo regular liver function tests (LFT) for abnormalities. Blood tests for LFTs should be performed every three to six months; liver ultrasound should be performed every six to 12 months. If no response is seen after three to four months, androgens should be discontinued [<xref ref-type="bibr" rid="fa.REF.scheckenbach.2012.128">Scheckenbach et al 2012</xref>, <xref ref-type="bibr" rid="fa.REF.rose.2014.11">Rose et al 2014</xref>].</p>
          <p><bold>Granulocyte colony-stimulating factor</bold> (G-CSF) improves the neutrophil count in some individuals. G-CSF dose should be titrated to the lowest possible dose and frequency to keep ANC above 1,000/mm<sup>3</sup>. Note: (1) A bone marrow aspirate and biopsy should be performed prior to the initiation of G-CSF and monitored every six months throughout treatment, given the theoretic risk of stimulating the growth of a leukemic clone. (2) G-CSF should be administered in consultation with an FA expert.</p>
          <p><bold>Hematopoietic stem cell transplantation</bold> (HSCT) is the only curative therapy for the hematologic manifestations, including aplastic anemia, myelodysplastic syndrome, and acute leukemia. Ideally, HSCT is performed prior to onset of MDS/AML and before multiple transfusions [<xref ref-type="bibr" rid="fa.REF.macmillan.2010.14">MacMillan &#x00026; Wagner 2010</xref>, <xref ref-type="bibr" rid="fa.REF.mehta.2010.180">Mehta et al 2010</xref>]. Individuals with FA are sensitive to chemotherapy and radiation, need special transplant regimens, and should be cared for and transplanted at centers with the most experience in HSCT in FA.</p>
          <p>A multi-institutional study reported a one-year probability of overall survival of 80% in 45 individuals with FA transplanted for marrow failure and/or MDS, using alternative donors (including mismatched related and unrelated donors) and chemotherapy-only preparative regimen. Survival for individuals younger than age ten years transplanted for marrow failure was even better, at 91.3% (&#x000b1;5.9%) [<xref ref-type="bibr" rid="fa.REF.mehta.2017">Mehta et al 2017</xref>].</p>
          <p><bold>Fludarabine</bold> reduced the incidence of graft failure and allowed for removal of radiation from the preparative regimens in a matched sib donor setting [<xref ref-type="bibr" rid="fa.REF.macmillan.2015.3798">MacMillan et al 2015</xref>].</p>
          <p><bold>MDS/AML</bold> treatment remains challenging. Options include chemotherapy, HSCT with or without prior induction chemotherapy, and investigational trials. Chemotherapy should be undertaken in coordination with centers experienced with FA, as it can cause severe, prolonged, or irreversible myelosuppression. Plans for HSCT should be in place prior to starting chemotherapy. Published reports of chemotherapy regimens for AML in individuals with FA are sparse and limited by the unclear benefit to the overall outcome due to the lack of longitudinal follow up [<xref ref-type="bibr" rid="fa.REF.mehta.2007.668">Mehta et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.talbot.2014.e199">Talbot et al 2014</xref>, <xref ref-type="bibr" rid="fa.REF.beier.2015.463">Beier et al 2015</xref>].</p>
          <p><bold>Solid tumors.</bold> Prompt, aggressive workup for any symptoms suggestive of a malignancy is indicated. Early detection and surgical removal remains the mainstay of therapy. Treatment is challenging secondary to the increased toxicity associated with chemotherapy and radiation in FA. Data is limited on use of chemotherapy at standard doses or reduced doses and schedules in individuals with FA, and there are reports of severe or fatal toxicities and poor treatment outcomes [<xref ref-type="bibr" rid="fa.REF.masserot.2008.3315">Masserot et al 2008</xref>, <xref ref-type="bibr" rid="fa.REF.hosoya.2010.805">Hosoya et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.tan.2011.e591">Tan et al 2011</xref>, <xref ref-type="bibr" rid="fa.REF.spanier.2012.510">Spanier et al 2012</xref>]. Individuals diagnosed with a genital tract cancer should be referred to a gynecologic oncologist immediately, and care should be coordinated with FA experts.</p>
        </sec>
        <sec id="fa.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Human papilloma virus (HPV) vaccination should be initiated at age nine years in order to reduce the risk of gynecologic cancer in females, and possibly reduce the risk of oral cancer in all individuals.</p>
        </sec>
        <sec id="fa.Prevention_of_Secondary_Complications">
          <title>Prevention of Secondary Complications</title>
          <p>Individuals with FA treated with HSCT who developed graft vs host disease (GVHD) had a 28% incidence of head and neck cancers in the ten years following treatment (vs 0% in those without GVHD); this finding points to the importance of minimizing the risk of GVHD [<xref ref-type="bibr" rid="fa.REF.guardiola.2004.73">Guardiola et al 2004</xref>]. Increased risk for GVHD observed in earlier studies was reduced significantly by T-cell depletion of the donor graft [<xref ref-type="bibr" rid="fa.REF.chaudhury.2008.644">Chaudhury et al 2008</xref>, <xref ref-type="bibr" rid="fa.REF.macmillan.2015.3798">MacMillan et al 2015</xref>].</p>
          <p>Individuals successfully treated with HSCT are at increased risk for solid tumors, in addition to the baseline increased risk [<xref ref-type="bibr" rid="fa.REF.rosenberg.2005.67">Rosenberg et al 2005</xref>]. Due to the known contribution of radiation to the long-term complication of secondary solid tumors most recent efforts have focused on using a conditioning regimen without radiation even in an unrelated donor setting. German, Brazilian, and US groups now report excellent outcomes with alternative donors with a 'chemotherapy-only' preparative regimen in single-center studies. The study from Germany showed 88% survival and normal hematopoiesis at a median follow up of 30 months [<xref ref-type="bibr" rid="fa.REF.bonfim.2015.s94a">Bonfim et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.chao.2015.1311">Chao et al 2015</xref>]. A prospective multi-institutional US study also showed similar excellent outcomes. One-year probabilities of overall and disease-free survival for the entire cohort, including patients with myeloid malignancy and those receiving mismatched related/haploidentical grafts, were 80% and 77.7% respectively at a median follow-up of 41 months. All young children (age &#x0003c;10 years) undergoing HSCT for marrow failure using low-dose busulfan-containing regimen survived [<xref ref-type="bibr" rid="fa.REF.mehta.2017">Mehta et al 2017</xref>].</p>
        </sec>
        <sec id="fa.Surveillance">
          <title>Surveillance</title>
          <p>See 2014 consensus guidelines [<xref ref-type="bibr" rid="fa.REF.frohnmayer.2014">Frohnmayer et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://fanconi.org/images/uploads/other/FA_Guidelines_4th_Edition_Revised_Names_in_Appendix.pdf">full text</ext-link>).</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual evaluation with a multidisciplinary team including an endocrinologist</p>
            </list-item>
            <list-item>
              <p>Regular blood counts, every three to four months while stable and more often as needed</p>
            </list-item>
            <list-item>
              <p>Bone marrow aspirate/biopsy at least annually to evaluate morphology, cellularity (from the biopsy), FISH, and cytogenetics (the latter two for emergence of a malignant clone). Individuals on GCSF need to have a bone marrow aspirate/biopsy every six months, if possible.</p>
            </list-item>
            <list-item>
              <p>In individuals who develop Sweet syndrome (neutrophilic skin infiltration), prompt investigation for hematologic disease progression including bone marrow evaluation</p>
            </list-item>
          </list>
          <p>Notes: (1) Progressively changing blood counts without a potential cause (e.g., acute infection or suppression from medication) require immediate evaluation with a complete blood count and bone marrow examination with FISH and cytogenetics. (2) It is important to recognize that rising blood counts can be due to either the development of MDS/AML or, rarely, reversion of a germline mutation in a stem cell, which repopulates the marrow with normal cells (somatic stem cell mosaicism). These individuals may require immediate HSCT (for MDS/AML) or continued close monitoring with complete blood counts at least every one to two months and a bone marrow examination with cytogenetics every six months.</p>
          <p>
            <bold>Individuals receiving androgen therapy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Liver function tests every three to six months</p>
            </list-item>
            <list-item>
              <p>Liver ultrasound examination every six to 12 months for androgen-related changes, including tumors</p>
            </list-item>
          </list>
          <p>
            <bold>Cancer surveillance</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Annual gynecologic assessment for genital lesions beginning at age 13. Thorough vulvo-vaginal examinations and Pap smear can begin when women become sexually active or by age 18 years, whichever is earlier. Suspicious genital tract lesions should be biopsied.</p>
            </list-item>
            <list-item>
              <p>Examination every six months for oral, head, and neck cancers beginning by age nine to ten years. Screening should be performed by a dentist, oral surgeon, or ENT familiar with FA. Nasolaryngoscopy starting at age ten years, or within the first year after HSCT. Individuals with difficulty or pain with swallowing should be evaluated for esophageal cancer.</p>
            </list-item>
            <list-item>
              <p>For individuals with a history of premalignant or malignant lesions: surveillance examinations every two to three months</p>
            </list-item>
            <list-item>
              <p>For individuals with biallelic pathogenic variants in <italic toggle="yes">BRCA2</italic>: screening for neuroblastomas, brain tumors, and kidney tumors every six months (see also <xref ref-type="sec" rid="fa.Risk_to_Family_Members__Autosomal_Rec">Risk to Family Members &#x02013; Autosomal Recessive FA</xref>)</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p><bold>Blood transfusions.</bold> Blood products should be cytomegalovirus (CMV)-safe and irradiated. To reduce the chances of sensitization, family members must not act as blood donors. Once an individual requires transfusions, he/she should be referred for transplantation.</p>
          <p><bold>Toxic agents</bold> to avoid include smoking, second-hand smoke, and alcohol, which have been implicated in tumorigenesis.</p>
          <p><bold>Unsafe sex practices</bold> increase the risk for HPV-associated malignancy.</p>
          <p><bold>Radiographic studies</bold> for the purpose of surveillance should be minimized in the absence of clinical indications. However, baseline skeletal surveys may be considered, in order to document bony anomalies that may lead to problems with age, such as anomalies of the wrist, hip, and vertebrae.</p>
        </sec>
        <sec id="fa.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate all sibs of an affected individual in order to identify as early as possible those who would benefit from appropriate monitoring for physical abnormalities, bone marrow failure, and related cancers.</p>
          <list list-type="bullet">
            <list-item>
              <p>DEB/MMC testing can be used to clarify the disease status of at-risk sibs.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant(s) in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk sibs.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="fa.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="fa.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Pregnancy is possible in females with FA, whether or not they have undergone hematopoietic stem cell transplantation [<xref ref-type="bibr" rid="fa.REF.dalle.2004.1099">Dalle et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.nabhan.2010.1783">Nabhan et al 2010</xref>].</p>
          <p>Pregnancy needs to be managed by a high-risk maternal fetal obstetrician along with a hematologist.</p>
        </sec>
        <sec id="fa.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Previous clinical trials failed to accomplish permanent gene correction of stem cells; current work is focusing on development of novel vector and delivery strategies [<xref ref-type="bibr" rid="fa.REF.tolar.2011.1193">Tolar et al 2011</xref>]. The first FA lentiviral gene therapy trial led by the University of Washington/Fred Hutchinson Cancer Research Center is now open [<xref ref-type="bibr" rid="fa.REF.becker.2010.1244">Becker et al 2010</xref>]. Dr. Juan Bueren has an open trial of a hematopoietic stem cell mobilization in Madrid, Spain and plans to have their <italic toggle="yes">FANCA</italic> gene therapy trial opened soon.</p>
          <p>A Phase I study of the antioxidant quercetin in children with Fanconi anemia is currently underway at Cincinnati Children's Hospital Medical Center.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="fa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="fa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Fanconi anemia (FA) is inherited in an autosomal recessive manner, an autosomal dominant manner (<italic toggle="yes">RAD51</italic>-related FA), or an X-linked manner (<italic toggle="yes">FANCB</italic>-related FA).</p>
        </sec>
        <sec id="fa.Risk_to_Family_Members__Autosomal_Rec">
          <title>Risk to Family Members &#x02014; Autosomal Recessive FA</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child with autosomal recessive FA are obligate heterozygotes (i.e., carriers of one FA-related pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are not at risk for FA. However, heterozygous mutation of a subset of FA-related genes (e.g. <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">PALB2</italic>, and <italic toggle="yes">BRIP1</italic>) is associated with an increased risk for breast and other cancers [<xref ref-type="bibr" rid="fa.REF.seal.2006.1239">Seal et al 2006</xref>, <xref ref-type="bibr" rid="fa.REF.berwick.2007.9591">Berwick et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.rahman.2007.165">Rahman et al 2007</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="brca1" document-type="chapter">Hereditary Breast and Ovarian Cancer</related-object>).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an individual with autosomal recessive FA has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are not at risk for FA. However, heterozygous mutation of a subset of FA-related genes (e.g. <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">PALB2</italic>, and <italic toggle="yes">BRIP1</italic>) is associated with an increased risk for breast and other cancers [<xref ref-type="bibr" rid="fa.REF.seal.2006.1239">Seal et al 2006</xref>, <xref ref-type="bibr" rid="fa.REF.berwick.2007.9591">Berwick et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.rahman.2007.165">Rahman et al 2007</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="brca1" document-type="chapter">Hereditary Breast and Ovarian Cancer</related-object>).</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive FA are obligate heterozygotes (carriers) for a pathogenic variant in an FA-related gene.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier for a pathogenic variant in an FA-related gene.</p>
          <p>
            <bold>Carrier (Heterozygote) Detection</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Carrier testing for at-risk relatives requires prior identification of the FA-related pathogenic variants in the family.</p>
            </list-item>
            <list-item>
              <p>Carriers of FA cannot be detected by the DEB/MMC test.</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Risk_to_Family_Members__Autosomal_Dom">
          <title>Risk to Family Members &#x02014; Autosomal Dominant FA</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To date, reported probands with <italic toggle="yes">RAD51</italic>-related FA have the disorder as a result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">RAD51</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> All affected individuals reported to date have had a <italic toggle="yes">de novo</italic>
<italic toggle="yes">RAD51</italic>-related FA pathogenic variant, suggesting a low risk to sibs. However, because of the theoretic possibility of germline mosaicism in a parent, the risk is presumed to be greater than in the general population.</p>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">RAD51</italic>-related FA is presumed to have a 50% chance of inheriting the pathogenic variant. However, only one individual with <italic toggle="yes">RAD51</italic>-related FA has reached adulthood and no offspring have been reported.</p>
          <p><bold>Other family members.</bold> Given that all probands with <italic toggle="yes">RAD51</italic>-related FA reported to date have the disorder as a result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">RAD51</italic> pathogenic variant, the risk to other family members is presumed to be low.</p>
        </sec>
        <sec id="fa.Risk_to_Family_Members__XLinked_FA">
          <title>Risk to Family Members &#x02014; X-Linked FA</title>
          <p>
            <bold>Parents of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a male with X-linked FA will not have the disorder nor will he be hemizygous for the <italic toggle="yes">FANCB</italic> pathogenic variant; therefore, he does not require further evaluation/testing.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate heterozygote (carrier).</p>
              <p>Note: If a woman has more than one affected son and if the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic>
<italic toggle="yes">FANCB</italic> pathogenic variant, in which case the mother is not a carrier.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a male proband.</bold> The risk to sibs depends on the genetic status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has a <italic toggle="yes">FANCB</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will usually not be affected.</p>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the <italic toggle="yes">FANCB</italic> pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Affected males transmit the <italic toggle="yes">FANCB</italic> pathogenic variant to all of their daughters (who will be carriers and will usually not be affected) and none of their sons.</p>
            </list-item>
            <list-item>
              <p>To date, no male with FA-B has been old enough to have children; they may also be infertile, as are many males with FA.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The proband's maternal aunts may be at risk of being heterozygotes (carriers) for the <italic toggle="yes">FANCB</italic> pathogenic variant and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
          <p>Note: Molecular genetic testing may be able to identify the family member in whom a <italic toggle="yes">de novo</italic> pathogenic variant arose &#x02013; information that could help determine genetic risk status of the extended family.</p>
        </sec>
        <sec id="fa.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <list list-type="bullet">
            <list-item>
              <p>Carrier testing for at-risk female relatives requires prior identification of the <italic toggle="yes">FANCB</italic> pathogenic variant in the family.</p>
            </list-item>
            <list-item>
              <p>Carriers of FA cannot be detected by the DEB/MMC test.</p>
            </list-item>
          </list>
        </sec>
        <sec id="fa.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="fa.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="fa.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the FA-related pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for FA are possible. Preimplantation genetic diagnosis has successfully identified at-risk embryos as unaffected with FA and HLA-matched to affected sibs [<xref ref-type="bibr" rid="fa.REF.kahraman.2014.340">Kahraman et al 2014</xref>].</p>
          <p><bold>Chromosome breakage.</bold> Prenatal testing is also possible for pregnancies at increased risk for FA by performing cytogenetic testing in the presence of DEB/MMC to evaluate for increased chromosome breakage in fetal cells obtained by chorionic villus sampling (CVS) or amniocentesis; however, if the pathogenic variants are known in the family, molecular genetic testing is the method of choice for prenatal diagnosis.</p>
          <p><bold>Fetal ultrasound evaluation.</bold> Ultrasound examination can be used to evaluate for fetal anomalies consistent with FA. However, ultrasound examination is not a diagnostic test for FA. Many congenital anomalies characteristic of FA may not be detectable by ultrasound examination, and those that can be seen may be associated with diagnoses other than FA.</p>
        </sec>
      </sec>
      <sec id="fa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="fa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object> for gene and protein names.</p>
        <p>For a table of Fanconi anemia-associated proteins and their function, click <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0092867414016377">here</ext-link> and download pdf [<xref ref-type="bibr" rid="fa.REF.wang.2015.354">Wang &#x00026; Smogorzewska 2015</xref>].</p>
        <sec id="fa.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>At least twenty genes that are involved in Fanconi anemia (FA) and also account for each of the phenotypic complementation groups have been identified. The proteins encoded by the FA-related genes are considered to work together in a common pathway/network called "the FA pathway" or "the FA-BRCA pathway/network," which regulates cellular resistance to DNA cross-linking agents [<xref ref-type="bibr" rid="fa.REF.taniguchi.2006.4223">Taniguchi &#x00026; D'Andrea 2006</xref>, <xref ref-type="bibr" rid="fa.REF.dandrea.2010.1909">D'Andrea 2010</xref>, <xref ref-type="bibr" rid="fa.REF.deans.2011.467">Deans &#x00026; West 2011</xref>, <xref ref-type="bibr" rid="fa.REF.kee.2012.3799">Kee &#x00026; D'Andrea 2012</xref>]. Disruption of this pathway leads to the common cellular and clinical abnormalities observed in FA [<xref ref-type="bibr" rid="fa.REF.dandrea.2010.1909">D'Andrea 2010</xref>, <xref ref-type="bibr" rid="fa.REF.nakanishi.2011.500">Nakanishi et al 2011</xref>, <xref ref-type="bibr" rid="fa.REF.williams.2011b.4395">Williams et al 2011b</xref>, <xref ref-type="bibr" rid="fa.REF.crossan.2012.326">Crossan &#x00026; Patel 2012</xref>, <xref ref-type="bibr" rid="fa.REF.kim.2012.1393">Kim &#x00026; D'Andrea 2012</xref>].</p>
          <p>Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM), along with proteins FAAP24 [<xref ref-type="bibr" rid="fa.REF.ciccia.2007.331">Ciccia et al 2007</xref>] and FAAP100 [<xref ref-type="bibr" rid="fa.REF.ling.2007.2104">Ling et al 2007</xref>] are assembled in a nuclear complex (FA core complex). This complex is a multi-subunit ubiquitin ligase complex; monoubiquitination of two FA proteins (FANCD2 and FANCI) depends on the FA core complex [<xref ref-type="bibr" rid="fa.REF.garciahiguera.2001.249">Garcia-Higuera et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>]. In response to DNA damage or in S phase of the cell cycle, this FA core complex activates the monoubiquitination of the FANCD2 and FANCI proteins. Monoubiquitinated FANCD2 and monoubiquitinated FANCI are translocated to nuclear foci containing the proteins BRCA1, BRCA2, PALB2, and RAD51. FANCI shares sequence similarity with FANCD2; together they form a protein complex (ID complex) [<xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>]. Monoubiquitination of FANCD2 and FANCI is interdependent [<xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>]. A nuclease, FAN1, has been shown to bind to monoubiquitinated FANCD2, which directs its enzymatic activity [<xref ref-type="bibr" rid="fa.REF.huang.2010.926">Huang &#x00026; D'Andrea 2010</xref>]. A cell-free system has been used to recapitulate cross-link repair in vitro [<xref ref-type="bibr" rid="fa.REF.knipscheer.2009.1698">Knipscheer et al 2009</xref>].</p>
          <p>One of the components of the FA core complex, FANCL, has a PHD (plant homeodomain) finger (a variant RING finger) domain with ubiquitin ligase activity [<xref ref-type="bibr" rid="fa.REF.meetei.2003a.165">Meetei et al 2003a</xref>]. FANCL associates through its PHD/RING finger domain with UBE2T, a ubiquitin conjugating enzyme (E2), which is also required for FANCD2 monoubiquitination [<xref ref-type="bibr" rid="fa.REF.machida.2006.589">Machida et al 2006</xref>]. Recombinant FANCL, the E2 UBE2T, FANCD2, FANCI, and FANCE recapitulate the monoubiquitination reaction in vitro [<xref ref-type="bibr" rid="fa.REF.alpi.2008.767">Alpi et al 2008</xref>].</p>
          <p>Another component of the FA core complex, FANCM, is homologous to the archaeal DNA helicase/nuclease known as HEF. FANCM has DNA helicase motifs and a degenerate nuclease motif and exhibits DNA-stimulated ATPase activity and DNA translocase activity [<xref ref-type="bibr" rid="fa.REF.meetei.2005.958">Meetei et al 2005</xref>]. A FANCM-interacting protein, FAAP24, preferentially binds to single-stranded DNA and branched DNA structures [<xref ref-type="bibr" rid="fa.REF.ciccia.2007.331">Ciccia et al 2007</xref>]. Therefore, it has been speculated that FANCM DNA translocase activity could play an important role in displacing the FA core complex along the DNA, allowing DNA damage recognition, or that FAAP24 may play a role in targeting the FA core complex to abnormal, branched DNA structures. This complex is thought to be responsible for a replication-associated checkpoint response involving RPA [<xref ref-type="bibr" rid="fa.REF.huang.2010.259">Huang et al 2010</xref>] and the BLM helicase [<xref ref-type="bibr" rid="fa.REF.deans.2009.943">Deans &#x00026; West 2009</xref>]. As is true for multiple FA proteins, the complex appears to be regulated through ATR [<xref ref-type="bibr" rid="fa.REF.collis.2008.313">Collis et al 2008</xref>].</p>
          <p>Furthermore, the FA core complex forms a larger complex with BLM, RPA, and topoisomerase III&#x003b1;, called BRAFT (<italic toggle="yes">B</italic>LM, <italic toggle="yes">R</italic>P<italic toggle="yes">A</italic>, <italic toggle="yes">F</italic>A, and <italic toggle="yes">t</italic>opoisomerase III&#x003b1;) [<xref ref-type="bibr" rid="fa.REF.meetei.2003b.3417">Meetei et al 2003b</xref>] in a further link to <related-object link-type="booklink" source-id="gene" document-id="bloom" document-type="chapter">Bloom syndrome</related-object>. FANCM is found in both separable complexes: the FA core complex as well as the BLM complex [<xref ref-type="bibr" rid="fa.REF.deans.2009.943">Deans &#x00026; West 2009</xref>].</p>
          <p>A DNA damage-activated signaling kinase, ATR, a single-strand DNA-binding protein complex, RPA, and an ATR-associated protein, HCLK2, are required for DNA damage-inducible monoubiquitnation and foci formation of FANCD2 [<xref ref-type="bibr" rid="fa.REF.andreassen.2004.1958">Andreassen et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.collis.2007.391">Collis et al 2007</xref>]. BRCA1 [<xref ref-type="bibr" rid="fa.REF.garciahiguera.2001.249">Garcia-Higuera et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.vandenberg.2003.247">Vandenberg et al 2003</xref>] and histone H2AX [<xref ref-type="bibr" rid="fa.REF.bogliolo.2007.1340">Bogliolo et al 2007</xref>] are required for DNA damage-inducible foci formation of FANCD2, but not for monoubiquitination of FANCD2. These factors are considered to be upstream positive regulators of the FA pathway. ATR has been shown to directly phosphorylate FANCA and indirectly phosphorylate FANCD2 through CHK1 [<xref ref-type="bibr" rid="fa.REF.zhi.2009.8775">Zhi et al 2009</xref>]. As described, ATR is also necessary for assembly of FANCM and recruitment of RPA at the ICL-induced checkpoint [<xref ref-type="bibr" rid="fa.REF.collis.2008.313">Collis et al 2008</xref>].</p>
          <p><italic toggle="yes">BRCA2</italic> (previously <italic toggle="yes">FANCD1</italic>) is a tumor suppressor that confers breast cancer susceptibility [<xref ref-type="bibr" rid="fa.REF.howlett.2002.606">Howlett et al 2002</xref>] and has a distinct clinical phenotype [<xref ref-type="bibr" rid="fa.REF.wagner.2004.3226">Wagner et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.alter.2007.1">Alter et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.myers.2012.462">Myers et al 2012</xref>]. BRCA2 protein stability and localization is regulated by PALB2 (partner and localizer of BRCA2) [<xref ref-type="bibr" rid="fa.REF.xia.2006.719">Xia et al 2006</xref>] encoded by <italic toggle="yes">PALB2</italic> (previously <italic toggle="yes">FANCN</italic>), another breast cancer susceptibility gene [<xref ref-type="bibr" rid="fa.REF.rahman.2007.165">Rahman et al 2007</xref>]. Another breast cancer susceptibility gene [<xref ref-type="bibr" rid="fa.REF.seal.2006.1239">Seal et al 2006</xref>], <italic toggle="yes">BRIP1</italic> (previously <italic toggle="yes">BACH1</italic> or <italic toggle="yes">FANCJ</italic>) [<xref ref-type="bibr" rid="fa.REF.cantor.2001.149">Cantor et al 2001</xref>], is also assoicated with FA [<xref ref-type="bibr" rid="fa.REF.levitus.2005.934">Levitus et al 2005</xref>, <xref ref-type="bibr" rid="fa.REF.levran.2005.931">Levran et al 2005</xref>, <xref ref-type="bibr" rid="fa.REF.litman.2005.255">Litman et al 2005</xref>]. <italic toggle="yes">BRCA2, PALB2</italic>, and <italic toggle="yes">BRIP1</italic> are not required for FANCD2 protein monoubiquitination or FANCD2 nuclear foci formation, but are still required for cellular resistance to MMC or DEB. BRCA2 has been found to act in multiple subcomplexes of FA proteins, including FANCG and FANCD2 [<xref ref-type="bibr" rid="fa.REF.wilson.2010.12">Wilson et al 2010</xref>], suggesting that the notion of acting downstream of FANCD2 monoubiquitination may be too simplistic. Phosphorylation of FANCD2 by CHK1 has been shown to be necessary for interaction with BRCA2 [<xref ref-type="bibr" rid="fa.REF.zhi.2009.8775">Zhi et al 2009</xref>]. BRIP1 and FANCD2 have also been shown to be functionally linked in foci formation [<xref ref-type="bibr" rid="fa.REF.zhang.2010.637">Zhang et al 2010</xref>].</p>
          <p>USP1 is a deubiquitinating enzyme that removes ubiquitin from monoubiquitinated FANCD2, and negatively regulates the FA pathway along with its coactivator UAF1 [<xref ref-type="bibr" rid="fa.REF.nijman.2005.331">Nijman et al 2005</xref>, <xref ref-type="bibr" rid="fa.REF.cohn.2007.786">Cohn et al 2007</xref>]. USP1 also removes ubiquitin from monoubiquitinated PCNA (<italic toggle="yes">p</italic>roliferating <italic toggle="yes">c</italic>ell <italic toggle="yes">n</italic>uclear <italic toggle="yes">a</italic>ntigen) [<xref ref-type="bibr" rid="fa.REF.huang.2006.339">Huang et al 2006</xref>]. This may not be coincidental, since FANCD2 and PCNA have been shown to bind [<xref ref-type="bibr" rid="fa.REF.howlett.2009.28935">Howlett et al 2009</xref>]. The deubiquitination event has been shown to be vital for FA function [<xref ref-type="bibr" rid="fa.REF.oestergaard.2007.798">Oestergaard et al 2007</xref>]. Hematopoeitic defects have been noted in knockout mice [<xref ref-type="bibr" rid="fa.REF.parmar.2010.1186">Parmar et al 2010</xref>].</p>
          <p>In nuclear foci, <italic toggle="yes">FANCD2</italic> colocalizes with <italic toggle="yes">FANCI, BRCA1, BRCA2, PALB2</italic>, <italic toggle="yes">RAD51, BLM, RPA, ATR, FANCC,</italic> and <italic toggle="yes">FANCE</italic> [<xref ref-type="bibr" rid="fa.REF.garciahiguera.2001.249">Garcia-Higuera et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.pace.2002.3414">Pace et al 2002</xref>, <xref ref-type="bibr" rid="fa.REF.taniguchi.2002a.2414">Taniguchi et al 2002a</xref>, <xref ref-type="bibr" rid="fa.REF.andreassen.2004.1958">Andreassen et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.wang.2004.5850">Wang et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.matsushita.2005.841">Matsushita et al 2005</xref>, <xref ref-type="bibr" rid="fa.REF.xia.2006.719">Xia et al 2006</xref>, <xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>]. FANCD2 also colocalizes partially with BRIP1 [<xref ref-type="bibr" rid="fa.REF.litman.2005.255">Litman et al 2005</xref>] and NBS1 [<xref ref-type="bibr" rid="fa.REF.nakanishi.2002.913">Nakanishi et al 2002</xref>]. All of these factors are required for cellular resistance to DNA cross-linking agents and are considered to work together to repair interstrand DNA cross-links, although the precise mechanism is not understood. Recently, pathogenic variants in <italic toggle="yes">RAD51C</italic> have been detected in several FA-like cases in a consanguineous family, also associated with breast and ovarian cancer susceptibility [<xref ref-type="bibr" rid="fa.REF.meindl.2010.410">Meindl et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.vaz.2010.406">Vaz et al 2010</xref>].</p>
          <p>Among FA proteins, BRCA2 has a clear role in regulating homologous recombination by controlling the activity of RAD51, the eukaryotic homolog of bacterial RecA [<xref ref-type="bibr" rid="fa.REF.davies.2001.273">Davies et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.moynahan.2001.263">Moynahan et al 2001</xref>]. PALB2 regulates <italic toggle="yes">BRCA2</italic> stability and localization in nuclear structures (chromatin and nuclear matrix) and, thus, is required for homologous recombination [<xref ref-type="bibr" rid="fa.REF.xia.2006.719">Xia et al 2006</xref>]. The FA core complex, FANCD2, FANCI [<xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>], and BRIP1 [<xref ref-type="bibr" rid="fa.REF.litman.2005.255">Litman et al 2005</xref>] are also reported to be required for efficient homologous recombination, although conflicting reports exist [<xref ref-type="bibr" rid="fa.REF.taniguchi.2006.4223">Taniguchi &#x00026; D'Andrea 2006</xref>].</p>
          <p>FANCD2 protein is also phosphorylated by the ataxia-telangiectasia kinase, ATM, in a process that regulates a radiation-induced S phase checkpoint [<xref ref-type="bibr" rid="fa.REF.taniguchi.2002b.459">Taniguchi et al 2002b</xref>, <xref ref-type="bibr" rid="fa.REF.ho.2006.7005">Ho et al 2006</xref>]. While required for resistance to ionizing radiation, this phosphorylation event is dispensable for cross-linker resistance, implying a separation of or dual function for FANCD2. FANCD2 appears to be phosphorylated by CHK1, which is downstream of ATR, at serine 331 in a manner that results in activation by cross-links [<xref ref-type="bibr" rid="fa.REF.zhi.2009.8775">Zhi et al 2009</xref>].</p>
          <p>Importantly, a number of studies have shown defects in the FA-BRCA pathway to be implicated in cancer:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with FA are susceptible to both leukemia and solid tumors [<xref ref-type="bibr" rid="fa.REF.alter.2003">Alter 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">Fancd2</italic>, <italic toggle="yes">Fanca</italic>, or <italic toggle="yes">Fancc</italic> knockout mice develop tumors [<xref ref-type="bibr" rid="fa.REF.houghtaling.2003.2021">Houghtaling et al 2003</xref>, <xref ref-type="bibr" rid="fa.REF.wong.2003.2063">Wong et al 2003</xref>, <xref ref-type="bibr" rid="fa.REF.carreau.2004.2430">Carreau 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Inactivation of the FA pathway by somatic methylation of <italic toggle="yes">FANCF</italic> has been found in a wide variety of human cancers (ovarian, breast, non-small cell lung, cervical, testicular, and head and neck squamous cell cancers) in the general population [<xref ref-type="bibr" rid="fa.REF.olopade.2003.417">Olopade &#x00026; Wei 2003</xref>, <xref ref-type="bibr" rid="fa.REF.taniguchi.2003.568">Taniguchi et al 2003</xref>, <xref ref-type="bibr" rid="fa.REF.marsit.2004.1000">Marsit et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.narayan.2004.2994">Narayan et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.wang.2006.256">Wang et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Inherited and somatic variants of <italic toggle="yes">FANCC</italic> and <italic toggle="yes">FANCG</italic> are present in a subset of young-onset pancreatic cancers [<xref ref-type="bibr" rid="fa.REF.van_der_heijden.2003.2585">van der Heijden et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> are well-known tumor suppressor genes responsible for familial breast/ovarian cancer [<xref ref-type="bibr" rid="fa.REF.turner.2004.814">Turner et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Pathogenic truncating variants in the FA-related genes <italic toggle="yes">BRIP1</italic> and <italic toggle="yes">PALB2</italic> are breast cancer susceptibility alleles [<xref ref-type="bibr" rid="fa.REF.seal.2006.1239">Seal et al 2006</xref>, <xref ref-type="bibr" rid="fa.REF.erkko.2007.316">Erkko et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.rahman.2007.165">Rahman et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.tischkowitz.2007.6788">Tischkowitz et al 2007</xref>].</p>
            </list-item>
          </list>
          <p>Amelioration of FA pathology has been implicated in reports of downregulation of elements of the non-homologous end-joining pathway [<xref ref-type="bibr" rid="fa.REF.adamo.2010.25">Adamo et al 2010</xref>]. These data propose that much of FA pathophysiology results from the unfettered work of NHEJ promoting inaccurate repair. On the other hand, FA involvement in homologous recombinatorial repair has been well established in interactions with BRCA1, BRCA2, and RAD51C. FANCD2 has also been shown to interact with PCNA and pol K, suggesting that translesion synthesis, a variant of homologous recombinantion, may be the most direct function of FA proteins in bypass of the lesion [<xref ref-type="bibr" rid="fa.REF.ho.2010.552">Ho &#x00026; Sch&#x000e4;rer 2010</xref>, <xref ref-type="bibr" rid="fa.REF.song.2010.31525">Song et al 2010</xref>].</p>
          <p>For reviews of the molecular biology of FA, see <xref ref-type="bibr" rid="fa.REF.nakanishi.2011.500">Nakanishi et al [2011]</xref>, <xref ref-type="bibr" rid="fa.REF.williams.2011b.4395">Williams et al [2011b]</xref>, <xref ref-type="bibr" rid="fa.REF.crossan.2012.326">Crossan &#x00026; Patel [2012]</xref>, <xref ref-type="bibr" rid="fa.REF.kim.2012.1393">Kim &#x00026; D'Andrea [2012]</xref>, and <xref ref-type="bibr" rid="fa.REF.huang.2014.1849">Huang et al [2014]</xref>.</p>
          <sec id="fa.BRCA2_previously_FANCD1">
            <title><italic toggle="yes">BRCA2</italic> (previously <italic toggle="yes">FANCD1</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">BRCA2</italic> has 27 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/119395733?">NM_000059.3</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> The breast cancer type 2 susceptibility protein (BRCA2) has 3418 amino acids. BRCA2 regulates homologous recombination repair through control of RAD51 recombinase [<xref ref-type="bibr" rid="fa.REF.davies.2001.273">Davies et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.moynahan.2001.263">Moynahan et al 2001</xref>]. Other functions of BRCA2 include stabilizing stalled replication forks and regulating cytokinesis [<xref ref-type="bibr" rid="fa.REF.daniels.2004.876">Daniels et al 2004</xref>]. BRCA2 works in concert with RAD51 to orchestrate the repair of double-strand break ends, prompting the nucleation of each end by RAD51. BRCA2 has been found in various subcomplexes with other FA proteins, including FANCG, FANCD2, and PALB2 [<xref ref-type="bibr" rid="fa.REF.xia.2007.159">Xia et al 2007</xref>, <xref ref-type="bibr" rid="fa.REF.wilson.2010.12">Wilson et al 2010</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.BRIP1_previously_FANCJ_or_BACH1">
            <title><italic toggle="yes">BRIP1</italic> (previously <italic toggle="yes">FANCJ</italic> or <italic toggle="yes">BACH1</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">BRIP1</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_032043.2">NM_032043.2</ext-link>) has 20 exons.</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> The Fanconi anemia group J protein (BRIP1 or FANCJ) has 1249 amino acids and is a DNA-dependent ATPase and a 5'-to-3' DNA helicase (DEAH helicase) that binds directly to the BRCT domain of BRCA1 [<xref ref-type="bibr" rid="fa.REF.cantor.2001.149">Cantor et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.chen.2014.25774">Chen et al 2014</xref>, <xref ref-type="bibr" rid="fa.REF.zou.2014.3685">Zou et al 2014</xref>]. FANCJ acetylation regulates DNA damage response [<xref ref-type="bibr" rid="fa.REF.xie.2012.e1002786">Xie et al 2012</xref>], and it contains the seven helicase-specific motifs and C-terminal extension, which has 39% homology with synaptonemal complex protein 1, a major component of the transverse filaments of developing meiotic chromosomes [<xref ref-type="bibr" rid="fa.REF.cantor.2001.149">Cantor et al 2001</xref>, <xref ref-type="bibr" rid="fa.REF.wu.2012.21699">Wu et al 2012</xref>, <xref ref-type="bibr" rid="fa.REF.brosh.2014.372">Brosh &#x00026; Cantor 2014</xref>, <xref ref-type="bibr" rid="fa.REF.sommers.2014.19928">Sommers et al 2014</xref>]. FANCJ engages stable G4/G-quadruplex structures [<xref ref-type="bibr" rid="fa.REF.sarkies.2012.1485">Sarkies et al 2012</xref>, <xref ref-type="bibr" rid="fa.REF.castillo_bosch.2014.2521">Castillo Bosch et al 2014</xref>], promotes stability of FAND2/FANCI [<xref ref-type="bibr" rid="fa.REF.zhang.2010.637">Zhang et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.clark.2015.28816">Clark et al 2015</xref>], and its helicase domain clearly is important for FA pathway function [<xref ref-type="bibr" rid="fa.REF.wu.2009.470">Wu &#x00026; Brosh 2009</xref>, <xref ref-type="bibr" rid="fa.REF.guo.2014.10551">Guo et al 2014</xref>]. FANCJ also appears to interdigitate with the mismatch repair pathway in binding to MLH1 [<xref ref-type="bibr" rid="fa.REF.cantor.2010.500">Cantor &#x00026; Xie 2010</xref>] and centrosome amplification [<xref ref-type="bibr" rid="fa.REF.zou.2013.1022">Zou et al 2013</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCA">
            <title>
              <italic toggle="yes">FANCA</italic>
            </title>
            <p><bold>Gene structure.</bold> The longest transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=66880552">NM_000135.2</ext-link> has 43 exons.</p>
            <p><bold>Pathogenic variants.</bold> The pathogenic variants of <italic toggle="yes">FANCA</italic> are numerous and highly variable among families [<xref ref-type="bibr" rid="fa.REF.levran.1997.13051">Levran et al 1997</xref>, <xref ref-type="bibr" rid="fa.REF.morgan.1999.1330">Morgan et al 1999</xref>, <xref ref-type="bibr" rid="fa.REF.wijker.1999.52">Wijker et al 1999</xref>]. A small percentage of families share the pathogenic variants p.Phe1263del and p.Val372AlafsTer42; the latter is found in affected individuals of northern European ancestry. See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <table-wrap id="fa.T.selected_fanca_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">FANCA</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1115_1118del</td>
                    <td headers="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val372AlafsTer42</td>
                    <td headers="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000135.2">NM_000135.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/66880553">NP_000126.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3788_3790del</td>
                    <td headers="hd_h_fa.T.selected_fanca_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe1263del</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> FANCA encoded by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=66880552">NM_000135.2</ext-link> has 1455 amino acids and is a component of the FA core complex. FANCA contains two overlapping bipartite nuclear localization signals (NLS), five functional leucine-rich nuclear export sequences, and a partial leucine zipper sequence [<xref ref-type="bibr" rid="fa.REF.fanconi_anaemiabreast_cancer_consortium.1996.324">Fanconi Anaemia/Breast Cancer Consortium 1996</xref>, <xref ref-type="bibr" rid="fa.REF.lo_ten_foe.1996.320">Lo Ten Foe et al 1996</xref>, <xref ref-type="bibr" rid="fa.REF.ferrer.2005.1271">Ferrer et al 2005</xref>]. The nuclear export of FANCA is regulated in a CRM1-dependent manner [<xref ref-type="bibr" rid="fa.REF.ferrer.2005.1271">Ferrer et al 2005</xref>]. FANCA is a phosphoprotein, a client of Hsp90 [<xref ref-type="bibr" rid="fa.REF.oda.2007.5016">Oda et al 2007</xref>]; it is phosphorylated by the ATR kinase at serine 1449 [<xref ref-type="bibr" rid="fa.REF.collins.2009.2181">Collins et al 2009</xref>]. Reports show that FANCA interacts with FA binding protein FAAP20 [<xref ref-type="bibr" rid="fa.REF.ali.2012.3285">Ali et al 2012</xref>, <xref ref-type="bibr" rid="fa.REF.leung.2012.4491">Leung et al 2012</xref>], is co-regulated with BRCA1 [<xref ref-type="bibr" rid="fa.REF.haitjema.2014.381">Haitjema et al 2014</xref>], and its deletion dysregulates murine T regulatory cells [<xref ref-type="bibr" rid="fa.REF.du.2014.1938">Du et al 2014</xref>]. With FANCC it modulates the toll-like receptor pathway [<xref ref-type="bibr" rid="fa.REF.garbati.2013.3197">Garbati et al 2013</xref>] and &#x02013; critically &#x02013; safeguards cell cycle integrity in hematopoietic cells [<xref ref-type="bibr" rid="fa.REF.abdulsater.2015.1031">Abdul-Sater et al 2015</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCB">
            <title>
              <italic toggle="yes">FANCB</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCB</italic> has ten exons with the translation start in exon 3 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/66528784?">NM_001018113.1</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> FANCB comprises 853 amino acids; some sequences have 859 residues, depending on the initiating methionine. FANCB is a component of the FA core complex and contains a putative bipartite NLS [<xref ref-type="bibr" rid="fa.REF.meetei.2004.1219">Meetei et al 2004</xref>]. FANCB is relevant to normal development &#x02013; as is evidenced by its dysfunction being linked to VACTERL association [<xref ref-type="bibr" rid="fa.REF.mccauley.2011.2370">McCauley et al 2011</xref>, <xref ref-type="bibr" rid="fa.REF.uma_a.2011.3071">Uma&#x000f1;a et al 2011</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See Molecular Genetic Pathogenesis.</p>
          </sec>
          <sec id="fa.FANCC">
            <title>
              <italic toggle="yes">FANCC</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCC</italic> has 15 exons.</p>
            <p><bold>Pathogenic variants.</bold> Three common pathogenic variants in <italic toggle="yes">FANCC</italic> have been identified (c.456+4A&#x0003e;T, c.1642C&#x0003e;T, and c.67delG) [<xref ref-type="bibr" rid="fa.REF.whitney.1993.202">Whitney et al 1993</xref>]. See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <table-wrap id="fa.T.selected_fancc_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p>Selected <italic toggle="yes">FANCC</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.456+4A&#x0003e;T&#x000a0;<sup>2,&#x000a0;3</sup><break/>(IVS4+4A&#x0003e;T)</td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=56118235">NM_000136.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/56118236">NP_000127.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.37C&#x0003e;T&#x000a0;<sup>3,&#x000a0;4</sup></td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln13Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.67delG&#x000a0;<sup>4,&#x000a0;5</sup><break/>(322delG)</td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp23IlefsTer23</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1642C&#x0003e;T&#x000a0;<sup>4,&#x000a0;5</sup></td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg548Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1661T&#x0003e;C&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_fa.T.selected_fancc_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu554Pro</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="fa.TF.4.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="fa.TF.4.2">
                  <label>2. </label>
                  <p>Found primarily in the Ashkenazi Jewish population; but also reported in a Japanese cohort.</p>
                </fn>
                <fn id="fa.TF.4.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="fa.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
                </fn>
                <fn id="fa.TF.4.4">
                  <label>4. </label>
                  <p>Prevalent in individuals of northern European ancestry</p>
                </fn>
                <fn id="fa.TF.4.5">
                  <label>5. </label>
                  <p>Found in individuals from southern Italy</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> FANCC has 558 amino acids. It is a component of the FA core complex, but localizes to both the nucleus and the cytoplasm [<xref ref-type="bibr" rid="fa.REF.yamashita.1994.6712">Yamashita et al 1994</xref>]. Some functions of FANCC outside of the FA core complex have also been proposed [<xref ref-type="bibr" rid="fa.REF.fagerlie.2004.3863">Fagerlie et al 2004</xref>]. Reports suggest that STAT1 binds to FANCC to modulate JAK-STAT signaling and to protect cells from interferon gamma toxic effects [<xref ref-type="bibr" rid="fa.REF.pang.2000.4724">Pang et al 2000</xref>, <xref ref-type="bibr" rid="fa.REF.fagerlie.2004.3863">Fagerlie et al 2004</xref>]. Further, FANCC binds to microtubule-associated protein stathmin-1 to regulate cytokinesis [<xref ref-type="bibr" rid="fa.REF.magron.2015.e0140612">Magron et al 2015</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCD2">
            <title>
              <italic toggle="yes">FANCD2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCD2</italic> has two transcript variants. Variant 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=66528797">NM_033084.3</ext-link>) has 43 exons; variant 2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=66528887">NM_001018115.1</ext-link>) has 44 exons and an alternate 3' coding sequence resulting in a shorter and distinct C-terminus. FANCD2 protein encoded by variant 2 (exon 44 form) is the functional FANCD2 protein, while the other transcript variant encodes a non-functional protein [<xref ref-type="bibr" rid="fa.REF.montes_de_oca.2005.1003">Montes de Oca et al 2005</xref>].</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> The functional FANCD2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001018125.1">NP_001018125.1</ext-link>) has 1451 amino acids (isoform b) and shares sequence similarity with FANCI. FANCD2 and FANCI form a protein complex (ID complex). FANCD2 can be monoubiquitinated on lysine 561 in an FA core complex-, UBE2T- (also known as FANCT [<xref ref-type="bibr" rid="fa.REF.hira.2015.1001">Hira et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.rickman.2015.35">Rickman et al 2015</xref>, <xref ref-type="bibr" rid="fa.REF.virts.2015.5093">Virts et al 2015</xref>]), and FANCI-dependent manner [<xref ref-type="bibr" rid="fa.REF.sato.2012.4553">Sato et al 2012</xref>, <xref ref-type="bibr" rid="fa.REF.rajendra.2014.858">Rajendra et al 2014</xref>]. Reports illuminated the structure of FANCI-FAND2 complex [<xref ref-type="bibr" rid="fa.REF.joo.2011.312">Joo et al 2011</xref>], its coordinate nuclear targeting [<xref ref-type="bibr" rid="fa.REF.boisvert.2013.e81387">Boisvert et al 2013</xref>], and its RAD18-mediated chromatin loading [<xref ref-type="bibr" rid="fa.REF.song.2010.31525">Song et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.williams.2011a.5078">Williams et al 2011a</xref>]. Monoubiquitinated FANCD2 is translocated to chromatin fraction &#x02013; recruited by UHRF1 [<xref ref-type="bibr" rid="fa.REF.liang.2015.1947">Liang et al 2015</xref>] &#x02013; to form nuclear foci with FANCI, BRCA1 (FANCS [<xref ref-type="bibr" rid="fa.REF.sawyer.2015.135">Sawyer et al 2015</xref>]), BRCA2, RAD51, and other partners. FANCD2 can be phosphorylated by ATM [<xref ref-type="bibr" rid="fa.REF.taniguchi.2002b.459">Taniguchi et al 2002b</xref>, <xref ref-type="bibr" rid="fa.REF.ho.2006.7005">Ho et al 2006</xref>] and by ATR [<xref ref-type="bibr" rid="fa.REF.andreassen.2004.1958">Andreassen et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.pichierri.2004.1178">Pichierri &#x00026; Rosselli 2004</xref>] in response to DNA damage. FANCD2 is phosphorylated at serine 331 by CHK1 in a manner that is required for binding to BRCA2 [<xref ref-type="bibr" rid="fa.REF.zhi.2009.8775">Zhi et al 2009</xref>]. Important studies have shown FANCD2 to have a function in resection of ends surrounding a cross-link in the repair process [<xref ref-type="bibr" rid="fa.REF.knipscheer.2009.1698">Knipscheer et al 2009</xref>], in replication fork processes [<xref ref-type="bibr" rid="fa.REF.zhu.2015b.1809">Zhu et al 2015b</xref>], binding to mini-chromosome maintenance proteins in control of replisome [<xref ref-type="bibr" rid="fa.REF.lossaint.2013.678">Lossaint et al 2013</xref>]. A nuclease, FAN1, has been demonstrated to bind to FANCD2 [<xref ref-type="bibr" rid="fa.REF.huang.2010.926">Huang &#x00026; D'Andrea 2010</xref>, <xref ref-type="bibr" rid="fa.REF.kratz.2010.77">Kratz et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.mackay.2010.65">MacKay et al 2010</xref>], and to promote DNA interstrand cross-link repair [<xref ref-type="bibr" rid="fa.REF.smogorzewska.2010.36">Smogorzewska et al 2010</xref>, <xref ref-type="bibr" rid="fa.REF.yoshikiyo.2010.21553">Yoshikiyo et al 2010</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCE">
            <title>
              <italic toggle="yes">FANCE</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCE</italic> has 14 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=66879667">NM_021922.2</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> FANCE has 536 amino acids and is a component of the FA core complex. FANCE directly binds to FANCD2 and recruits it to the FA E3 ligase complex [<xref ref-type="bibr" rid="fa.REF.polito.2014.7003">Polito et al 2014</xref>]. FANCE contains two nuclear localization signals (NLS) and its nuclear accumulation depends on FANCC [<xref ref-type="bibr" rid="fa.REF.l_veill_.2006.556">L&#x000e9;veill&#x000e9; et al 2006</xref>]. FANCE has five tandem repeats of a short helical motif (FANC repeats) [<xref ref-type="bibr" rid="fa.REF.nookala.2007.1638">Nookala et al 2007</xref>]. It functions as a shuttle protein between the FA core complex and FANCD2 in a fashion dependent on phosphorylation [<xref ref-type="bibr" rid="fa.REF.wang.2007.3098">Wang et al 2007</xref>], with functionality dependent on alternative splicing [<xref ref-type="bibr" rid="fa.REF.bouffard.2015.3056">Bouffard et al 2015</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCF">
            <title>
              <italic toggle="yes">FANCF</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCF</italic> has a single exon (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=42716285">NM_022725.2</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> FANCF has 374 amino acids and is a component of the FA core complex. FANCF acts as a flexible adaptor protein required for the assembly of the FA core complex [<xref ref-type="bibr" rid="fa.REF.l_veill_.2004.39421">L&#x000e9;veill&#x000e9; et al 2004</xref>]. Crystallographic studies of the C-terminal domain revealed a helical repeat structure similar to the Cand1 regulator of the Cul1-Rbx1-Skp1-Fbox(Skp2) ubiquitin ligase complex [<xref ref-type="bibr" rid="fa.REF.kowal.2007.2047">Kowal et al 2007</xref>], and &#x02013; recently &#x02013; next-generation sequencing refined genotype-phenotype correlations [<xref ref-type="bibr" rid="fa.REF.nicchia.2015.1003">Nicchia et al 2015</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCG">
            <title>
              <italic toggle="yes">FANCG</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCG</italic> has 14 exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=4759335">NM_004629.1</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic variants in <italic toggle="yes">FANCG</italic> are highly variable, but more common variant alleles have been described in specific populations: c.307+1G&#x0003e;C (Korean/Japanese), c.925-2A&#x0003e;G (Brazilian), c.1480+1G&#x0003e;C (French Canadian), and p.Gly395TrpfsTer5 [<xref ref-type="bibr" rid="fa.REF.demuth.2000.861">Demuth et al 2000</xref>] and p.Trp599ProfsTer49 [<xref ref-type="bibr" rid="fa.REF.auerbach.2003.158">Auerbach et al 2003</xref>] (northern European). See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <table-wrap id="fa.T.selected_fancg_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">FANCG</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.307+1G&#x0003e;C<break/>(IVS3+1G&#x0003e;C)</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/4759335">NM_004629.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4759336">NP_004620.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.925-2A&#x0003e;G<break/>(IVS8-2A&#x0003e;G)</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1183-1192del<break/>(1184-1194del)</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu395TrpfsTer5</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1480+1G&#x0003e;C<break/>(IVS11+1G&#x0003e;C)</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp599ProfsTer49</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.1794_1803del</td>
                    <td headers="hd_h_fa.T.selected_fancg_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="fa.TF.5.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> FANCG has 622 amino acids. It is a component of the FA core complex. FANCG has seven tetratricopeptide repeat motifs [<xref ref-type="bibr" rid="fa.REF.blom.2004.77">Blom et al 2004</xref>, <xref ref-type="bibr" rid="fa.REF.wilson.2010.12">Wilson et al 2010</xref>]. FANCG is a phosphoprotein; serines 383 and 387 on FANCG are phosphorylated in M phase, presumably by cdc2 [<xref ref-type="bibr" rid="fa.REF.mi.2004.8576">Mi et al 2004</xref>]. These two sites are important for exclusion of FANCG from chromatin in mitosis. Phosphorylation of serine 7 of FANCG is upregulated after MMC treatment [<xref ref-type="bibr" rid="fa.REF.qiao.2004.46035">Qiao et al 2004</xref>]. FANCA and FANCG stabilize each other, and FANCG, BRCA2, FANCD2, and XRCC3 participate in the same protein complex. This implies multifunctionality of FANCG by its presence in the core complex as well as in homologous recombinatorial repair [<xref ref-type="bibr" rid="fa.REF.wang.2007.3098">Wang et al 2007</xref>]. FANCG further associates with Rap80-BRCA1 complex in DNA repair mediated by homologous recombination [<xref ref-type="bibr" rid="fa.REF.zhu.2015a.2867">Zhu et al 2015a</xref>], and it is operational in homing of hematopoietic stem cells [<xref ref-type="bibr" rid="fa.REF.barroca.2012.121">Barroca et al 2012</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          </sec>
          <sec id="fa.FANCI">
            <title>
              <italic toggle="yes">FANCI</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FANCI</italic> has 37 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=82830439">NM_018193.2</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> See <related-object source-id="gene" document-id="fa" object-id="fa.molgen.TA">Table A</related-object>.</p>
            <p><bold>Normal gene product.</bold> FANCI has 1268 amino acids and shares sequence similarity with FANCD2. FANCD2 and FANCI form a protein complex (ID complex). FANCI can be monoubiquitinated on lysine 523 in an FA core complex-, UBE2T-, and FANCD2-dependent manner. Monoubiquitinated FANCI is translocated to nuclear foci and colocalizes with BRCA1, BRCA2, RAD51, FANCD2 [<xref ref-type="bibr" rid="fa.REF.boisvert.2014.2999">Boisvert &#x00026; Howlett 2014</xref>, <xref ref-type="bibr" rid="fa.REF.rajendra.2014.858">Rajendra et al 2014</xref>]. FANCI is a phosphoprotein. DNA damage-induced phosphorylation of p.Ser730, p.Thr952, and p.Ser1121 of human FANCI can be detected [<xref ref-type="bibr" rid="fa.REF.smogorzewska.2007.289">Smogorzewska et al 2007</xref>]. FANCI functions in an analogous manner as FANCD2 and can be analyzed in the same fashion in assays including DNA repair foci, cell survival, and monoubiquitination [<xref ref-type="bibr" rid="fa.REF.ishiai.2008.1138">Ishiai et al 2008</xref>]. Reports illuminated the structure of FANCI-FAND2 complex [<xref ref-type="bibr" rid="fa.REF.joo.2011.312">Joo et al 2011</xref>], its coordinate nuclear targeting [<xref ref-type="bibr" rid="fa.REF.boisvert.2013.e81387">Boisvert et al 2013</xref>], and &#x02013; remarkably &#x02013; its FANCD2-independent function upstream of FA core complex recruitment [<xref ref-type="bibr" rid="fa.REF.castella.2015.e1005563">Castella et al 2015</xref>].</p>
            <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="fa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
            <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="fa-less_common_genes.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for information on the genes less commonly involved in Fanconi Anemia (from <xref ref-type="table" rid="fa.T.molecular_genetics_of_fanconi_anemi_1">Table 1b</xref>).</p>
          </sec>
        </sec>
      </sec>
      <sec id="fa.References">
        <title>References</title>
        <sec id="fa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="fa.Literature_Cited.reflist0">
            <ref id="fa.REF.abdulsater.2015.1031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abdul-Sater</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerabona</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potchanant</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enzor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalepa</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>FANCA safeguards interphase and mitosis during hematopoiesis in vivo.</article-title>
                <source>Exp Hematol.</source>
                <year>2015</year>
                <volume>43</volume>
                <fpage>1031</fpage>
                <lpage>46.e12</lpage>
                <pub-id pub-id-type="pmid">26366677</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.adamo.2010.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adamo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collis</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adelman</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horejsi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Perez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulton</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Volpe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia.</article-title>
                <source>Mol Cell.</source>
                <volume>39</volume>
                <fpage>25</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">20598602</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ali.2012.3285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pradhan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahengbam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grassman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.</article-title>
                <source>Blood.</source>
                <year>2012</year>
                <volume>119</volume>
                <fpage>3285</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">22343915</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.alpi.2008.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alpi</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pace</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babu</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI.</article-title>
                <source>Mol Cell.</source>
                <volume>32</volume>
                <fpage>767</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">19111657</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.alter.2003">
              <mixed-citation publication-type="book">Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. <italic toggle="yes">Nathan and Oski's Hematology of Infancy and Childhood</italic>. 6 ed. Philadelphia, PA: WB Saunders; 2003:280-365.</mixed-citation>
            </ref>
            <ref id="fa.REF.alter.2006.446">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The association between FANCD1/BRCA2 mutations and leukaemia.</article-title>
                <source>Br J Haematol.</source>
                <volume>133</volume>
                <fpage>446</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16643458</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.alter.2010.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loud</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leathwood</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.</article-title>
                <source>Br J Haematol.</source>
                <volume>150</volume>
                <fpage>179</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">20507306</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.alter.2007.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brody</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.</article-title>
                <source>J Med Genet.</source>
                <volume>44</volume>
                <fpage>1</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16825431</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ameziane.2015.8829">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ameziane</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>May</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haitjema</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Vrugt</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rossum-Fikkert</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ristic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rockx</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velleuer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietrich</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleijerveld</surname>
                    <given-names>OB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maarten Altelaar</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glusman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hood</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balling</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Dunnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelinas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsman</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.</article-title>
                <source>Nat Commun.</source>
                <year>2015</year>
                <volume>6</volume>
                <fpage>8829</fpage>
                <pub-id pub-id-type="pmid">26681308</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.andreassen.2004.1958">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>ATR couples FANCD2 monoubiquitination to the DNA-damage response.</article-title>
                <source>Genes Dev</source>
                <volume>18</volume>
                <fpage>1958</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">15314022</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.auerbach.2003.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenbaum</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitencourt</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokemohr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobitzc</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giampietro</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levran</surname>
                    <given-names>O</given-names>
                  </name>
                  <collab>International Fanconi Anemia Registry</collab>
                </person-group>
                <article-title>Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.</article-title>
                <source>Hum Mutat.</source>
                <year>2003</year>
                <volume>21</volume>
                <fpage>158</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">12552564</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.barroca.2012.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barroca</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouthon</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewandowski</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet de la Grange</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pflumio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussin</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arwert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riou</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allemand</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romeo</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fouchet</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Impaired functionality and homing of Fancg-deficient hematopoietic stem cells.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>121</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">21968513</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.becker.2010.1244">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trobridge</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beard</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adair</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohn</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiem</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <article-title>Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.</article-title>
                <source>Gene Ther.</source>
                <year>2010</year>
                <volume>17</volume>
                <fpage>1244</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">20485382</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.beier.2015.463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maecker-Kolhoff</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykora</surname>
                    <given-names>K-W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kratz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauer</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <article-title>Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.</article-title>
                <source>Bone Marrow Transplant</source>
                <year>2015</year>
                <volume>50</volume>
                <fpage>463</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">25531282</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.berwick.2007.9591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berwick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Porat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mah</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diotti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landers</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dev Batish</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hromas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levran</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.</article-title>
                <source>Cancer Res.</source>
                <year>2007</year>
                <volume>67</volume>
                <fpage>9591</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17909071</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.blom.2004.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Vrugt</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arwert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Multiple TPR motifs characterize the Fanconi anemia FANCG protein.</article-title>
                <source>DNA Repair (Amst)</source>
                <volume>3</volume>
                <fpage>77</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">14697762</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.bluteau.2016.3580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bluteau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masliah-Planchon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clairmont</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rousseau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceccaldi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois d'Enghien</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bluteau</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuccuini</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gachet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peffault de Latour</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruchel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soulier</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Biallelic inactivation of REV7 is associated with Fanconi anemia.</article-title>
                <source>J Clin Invest.</source>
                <year>2016</year>
                <volume>126</volume>
                <fpage>3580</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">27500492</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.bogliolo.2007.1340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bogliolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyakhovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Call&#x000e9;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castell&#x000e0;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappelli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcos</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surrall&#x000e9;s</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.</article-title>
                <source>EMBO J.</source>
                <volume>26</volume>
                <fpage>1340</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17304220</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.bogliolo.2013.800">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bogliolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuster</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoepker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Derkunt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trujillo</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minguill&#x000f3;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casado</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ba&#x000f1;os</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knies</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fa;&#x000f1;iga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben&#x000ed;tez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueren</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;rer</surname>
                    <given-names>OD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surrall&#x000e9;s</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>92</volume>
                <fpage>800</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23623386</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.bonfim.2015.s94a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonfim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riberio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichele</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loth</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwahara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koliski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitencourt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodrigues</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilonetto</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>R.</given-names>
                  </name>
                </person-group>
                <article-title>Excellent outcomes for Fanconi anemia patients undergoing hematopoietic stem cell transplantation (HSCT) without radiation: a single center experience on 103 patients.</article-title>
                <source>Biol Blood Marrow Transplant</source>
                <year>2015</year>
                <volume>21</volume>
                <fpage>S94a</fpage>
              </element-citation>
            </ref>
            <ref id="fa.REF.boisvert.2014.2999">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boisvert</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howlett</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <article-title>The Fanconi anemia ID2 complex: dueling saxes at the crossroads.</article-title>
                <source>Cell Cycle.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>2999</fpage>
                <lpage>3015</lpage>
                <pub-id pub-id-type="pmid">25486561</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.boisvert.2013.e81387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boisvert</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rego</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzinaro</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mauro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howlett</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <article-title>Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e81387</fpage>
                <pub-id pub-id-type="pmid">24278431</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.bouffard.2015.3056">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouffard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plourde</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;langer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouellette</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labrie</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durocher</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of a FANCE Splice Isoform in Regard to DNA Repair.</article-title>
                <source>J Mol Biol.</source>
                <year>2015</year>
                <volume>427</volume>
                <fpage>3056</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">26277624</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.brosh.2014.372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brosh</surname>
                    <given-names>RM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia.</article-title>
                <source>Front Genet.</source>
                <year>2014</year>
                <volume>5</volume>
                <fpage>372</fpage>
                <pub-id pub-id-type="pmid">25374583</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.byrd.2016.e1005945">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Byrd</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eaton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eringyte</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fooks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Last</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsley</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dokmanovic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>A hypomorphic PALB2 allele gives rise to an unusual form of FA-N associated with lymphoid tumour development.</article-title>
                <source>PLoS Genet.</source>
                <year>2016</year>
                <volume>12</volume>
                <fpage>e1005945</fpage>
                <pub-id pub-id-type="pmid">26990772</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.cantor.2001.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganesan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kass</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drapkin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahrer</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sgroi</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.</article-title>
                <source>Cell.</source>
                <volume>105</volume>
                <fpage>149</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11301010</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.cantor.2010.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair.</article-title>
                <source>Environ Mol Mutagen.</source>
                <volume>51</volume>
                <fpage>500</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20658644</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.carreau.2004.2430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carreau</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Not-so-novel phenotypes in the Fanconi anemia group D2 mouse model.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>2430</fpage>
                <pub-id pub-id-type="pmid">14998919</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.castella.2015.e1005563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeo</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobeck</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickson</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>FANCI regulates recruitment of the FA core complex at sites of DNA damage independently of FANCD2.</article-title>
                <source>PLoS Genet.</source>
                <year>2015</year>
                <volume>11</volume>
                <fpage>e1005563</fpage>
                <pub-id pub-id-type="pmid">26430909</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.castillo_bosch.2014.2521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castillo Bosch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segura-Bayona</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koole</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heteren</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewar</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijsterman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knipscheer</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>FANCJ promotes DNA synthesis through G-quadruplex structures.</article-title>
                <source>EMBO J.</source>
                <year>2014</year>
                <volume>33</volume>
                <fpage>2521</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">25193968</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.chao.2015.1311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuehl</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemeyer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Bernuth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rascon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kratz</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebell</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.</article-title>
                <source>Ann Hematol.</source>
                <year>2015</year>
                <volume>94</volume>
                <fpage>1311</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25862235</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.chandrasekharappa.2013.e138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandrasekharappa</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimble</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teer</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donovan</surname>
                    <given-names>FX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flynn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sen</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thongthip</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanborn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostrander</surname>
                    <given-names>EA</given-names>
                  </name>
                  <collab>NISC Comparative Sequencing Program</collab>
                </person-group>
                <article-title>Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.</article-title>
                <source>Blood.</source>
                <year>2013</year>
                <volume>121</volume>
                <fpage>e138</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">23613520</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.chaudhury.2008.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaudhury</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kernan</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Small</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prockop</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaradavou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolden</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Reilly</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulad</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.</article-title>
                <source>Br J Haematol.</source>
                <year>2008</year>
                <volume>140</volume>
                <fpage>644</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">18302713</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.chen.2014.25774">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McChesney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longerich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marriott</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.</article-title>
                <source>J Biol Chem.</source>
                <year>2014</year>
                <volume>289</volume>
                <fpage>25774</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">25070891</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.chrzanowska.2012.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dembowska-Bagi&#x00144;ska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalina</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Nijmegen breakage syndrome (NBS).</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>13</fpage>
                <pub-id pub-id-type="pmid">22373003</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ciccia.2007.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ciccia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulthard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Laghmani el H, Joenje H, McDonald N, de Winter JP, Wang W, West SC. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.</article-title>
                <source>Mol Cell.</source>
                <year>2007</year>
                <volume>25</volume>
                <fpage>331</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">17289582</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.clark.2015.28816">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tripathi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsman</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palle</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.</article-title>
                <source>Oncotarget.</source>
                <year>2015</year>
                <volume>6</volume>
                <fpage>28816</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">26336824</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.cohn.2007.786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gygi</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.</article-title>
                <source>Mol Cell.</source>
                <volume>28</volume>
                <fpage>786</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">18082604</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.collins.2009.2181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bush</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomashevski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.</article-title>
                <source>Blood.</source>
                <volume>113</volume>
                <fpage>2181</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19109555</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.collis.2008.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Collis</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deans</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horejs&#x000ed;</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maslen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skehel</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulton</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex.</article-title>
                <source>Mol Cell.</source>
                <volume>32</volume>
                <fpage>313</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">18995830</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.collis.2007.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Collis</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulton</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability.</article-title>
                <source>Nat Cell Biol</source>
                <volume>9</volume>
                <fpage>391</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">17384638</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.crossan.2012.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crossan</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <article-title>The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA.</article-title>
                <source>J Pathol.</source>
                <year>2012</year>
                <volume>226</volume>
                <fpage>326</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">21956823</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.dandrea.2010.1909">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Susceptibility pathways in Fanconi's anemia and breast cancer.</article-title>
                <source>N Engl J Med.</source>
                <year>2010</year>
                <volume>362</volume>
                <fpage>1909</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">20484397</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.dalle.2004.1099">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dalle</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duval</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rousseau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francoeur</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champagne</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vachon</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champagne</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Successful pregnancies after bone marrow transplantation for Fanconi anemia.</article-title>
                <source>Bone Marrow Transplant.</source>
                <volume>34</volume>
                <fpage>1099</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">15489874</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.daniels.2004.876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkitaraman</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.</article-title>
                <source>Science</source>
                <volume>306</volume>
                <fpage>876</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15375219</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.davies.2001.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masson</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIlwraith</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasiak</surname>
                    <given-names>AZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasiak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkitaraman</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.</article-title>
                <source>Mol Cell.</source>
                <volume>7</volume>
                <fpage>273</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11239456</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.deans.2009.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deans</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia.</article-title>
                <source>Mol Cell.</source>
                <volume>36</volume>
                <fpage>943</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20064461</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.deans.2011.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deans</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <article-title>DNA interstrand crosslink repair and cancer.</article-title>
                <source>Nat Rev Cancer.</source>
                <year>2011</year>
                <volume>11</volume>
                <fpage>467</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">21701511</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.demuth.2000.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demuth</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wlodarski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tipping</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000e4;sl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatterale</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebell</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>8</volume>
                <fpage>861</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11093276</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.du.2014.1938">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erden</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sipple</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbrecher</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <article-title>Deletion of Fanca or Fancd2 dysregulates Treg in mice.</article-title>
                <source>Blood.</source>
                <year>2014</year>
                <volume>123</volume>
                <fpage>1938</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">24501220</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.erkko.2007.316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erkko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikkil&#x000e4;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schleutker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syrj&#x000e4;koski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannermaa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallioniemi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pylk&#x000e4;s</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karppinen</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapakko</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattila</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grip</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jukkola-Vuorinen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mustonen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kere</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosma</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kataja</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soini</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drapkin</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winqvist</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A recurrent mutation in PALB2 in Finnish cancer families.</article-title>
                <source>Nature.</source>
                <volume>446</volume>
                <fpage>316</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17287723</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.fagerlie.2004.3863">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fagerlie</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koretsky</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torok-Storb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagby</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.</article-title>
                <source>J Immunol</source>
                <volume>173</volume>
                <fpage>3863</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">15356134</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.faivre.2000.4064">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guardiola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dokal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebell</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatterale</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stones</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwee</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Weel-Sipman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Havenga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ravel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group.</article-title>
                <source>Blood</source>
                <volume>96</volume>
                <fpage>4064</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11110674</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.faivre.2005.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portnoi</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Should chromosome breakage studies be performed in patients with VACTERL association?</article-title>
                <source>Am J Med Genet A</source>
                <volume>137</volume>
                <fpage>55</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16015582</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.fanconi_anaemiabreast_cancer_consortium.1996.324">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>Fanconi Anaemia/Breast Cancer Consortium</collab>
                </person-group>
                <year>1996</year>
                <article-title>Positional cloning of the Fanconi anaemia group A gene.</article-title>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>324</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8896564</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ferrer.2005.1271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spierings</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruyt</surname>
                    <given-names>FA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>1271</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">15790592</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.frohnmayer.2014">
              <mixed-citation publication-type="web">Frohnmayer D, Frohnmayer L, Guinan E, Kennedy T, Larsen K, eds. <italic toggle="yes">Fanconi Anemia: Guidelines for Diagnosis and Management.</italic> 4 ed. Eugene, OR: Fanconi Anemia Research Fund, Inc. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://fanconi.org/images/uploads/other/FA_Guidelines_4th_Edition_Revised_Names_in_Appendix.pdf">online</ext-link>. 2014. Accessed 3-21-17.</mixed-citation>
            </ref>
            <ref id="fa.REF.futaki.2000.1493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Futaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.</article-title>
                <source>Blood</source>
                <volume>95</volume>
                <fpage>1493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10666230</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.garbati.2013.3197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garbati</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeble</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rathbun</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagby</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <article-title>FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1&#x003b2; in macrophages.</article-title>
                <source>Blood.</source>
                <year>2013</year>
                <volume>122</volume>
                <fpage>3197</fpage>
                <lpage>205</lpage>
                <pub-id pub-id-type="pmid">24046015</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.garciahiguera.2001.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Higuera</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganesan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyn</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejna</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.</article-title>
                <source>Mol Cell</source>
                <volume>7</volume>
                <fpage>249</fpage>
                <pub-id pub-id-type="pmid">11239454</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.gillio.1997.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gillio</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verlander</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giampietro</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.</article-title>
                <source>Blood</source>
                <volume>90</volume>
                <fpage>105</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9207444</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.giulino.2011.278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giulino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guinan</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillio</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drachtman</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teruya-Feldstein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulad</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease.</article-title>
                <source>Br J Haematol.</source>
                <year>2011</year>
                <volume>154</volume>
                <fpage>278</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">21501135</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.guardiola.2004.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guardiola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribaud</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devergie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esp&#x000e9;rou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traineau</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.</article-title>
                <source>Blood.</source>
                <year>2004</year>
                <volume>103</volume>
                <fpage>73</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12946993</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.guo.2014.10551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidhyasagar</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Insight into the roles of helicase motif Ia by characterizing Fanconi anemia group J protein (FANCJ) patient mutations.</article-title>
                <source>J Biol Chem.</source>
                <year>2014</year>
                <volume>289</volume>
                <fpage>10551</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">24573678</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.haitjema.2014.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haitjema</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mol</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kooi</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massink</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f8;rgensen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rockx</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsman</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>Coregulation of FANCA and BRCA1 in human cells.</article-title>
                <source>Springerplus.</source>
                <year>2014</year>
                <volume>3</volume>
                <fpage>381</fpage>
                <pub-id pub-id-type="pmid">25161863</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.hira.2015.1001">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiraishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiba</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kojima</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurumizaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>96</volume>
                <fpage>1001</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26046368</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.hirsch.2004.2554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hag-alshiekh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bostrom</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sencer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>2554</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14670928</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ho.2006.7005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margossian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.</article-title>
                <source>Mol Cell Biol</source>
                <volume>26</volume>
                <fpage>7005</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">16943440</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ho.2010.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;rer</surname>
                    <given-names>OD</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.</article-title>
                <source>Environ Mol Mutagen.</source>
                <volume>51</volume>
                <fpage>552</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20658647</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.hosoya.2010.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hosoya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirashima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nokubi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jinbu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muroi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.</article-title>
                <source>Jpn J Clin Oncol.</source>
                <year>2010</year>
                <volume>40</volume>
                <fpage>805</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20410055</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.houghtaling.2003.2021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Houghtaling</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noll</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finegold</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyn</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.</article-title>
                <source>Genes Dev.</source>
                <volume>17</volume>
                <fpage>2021</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">12893777</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.howlett.2002.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howlett</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Die-Smulders</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persky</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Biallelic inactivation of BRCA2 in Fanconi anemia.</article-title>
                <source>Science</source>
                <volume>297</volume>
                <fpage>606</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12065746</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.howlett.2009.28935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howlett</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rego</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolling</surname>
                    <given-names>FW</given-names>
                    <suffix>4th</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Glover</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif.</article-title>
                <source>J Biol Chem.</source>
                <volume>284</volume>
                <fpage>28935</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19704162</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.huang.2010.926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A new nuclease member of the FAN club.</article-title>
                <source>Nat Struct Mol Biol.</source>
                <volume>17</volume>
                <fpage>926</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20683477</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.huang.2010.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiotani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response.</article-title>
                <source>Mol Cell.</source>
                <volume>39</volume>
                <fpage>259</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">20670894</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.huang.2014.1849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowery</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Modularized functions of the Fanconi anemia core complex.</article-title>
                <source>Cell Rep.</source>
                <year>2014</year>
                <volume>7</volume>
                <fpage>1849</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">24910428</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.huang.2006.339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijman</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirchandani</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galardy</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gygi</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploegh</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernards</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Regulation of monoubiquitinated PCNA by DUB autocleavage.</article-title>
                <source>Nat Cell Biol.</source>
                <volume>8</volume>
                <fpage>339</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">16531995</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ishiai.2008.1138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishiai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomida</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinomura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saberi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita-Kikuta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tashiro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.</article-title>
                <source>Nat Struct Mol Biol.</source>
                <volume>15</volume>
                <fpage>1138</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">18931676</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.jones.2009.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruban</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borges</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmisano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brune</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaffee</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobuzio-Donahue</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maitra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velculescu</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshleman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goggins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.</article-title>
                <source>Science.</source>
                <year>2009</year>
                <volume>324</volume>
                <fpage>217</fpage>
                <pub-id pub-id-type="pmid">19264984</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.joo.2011.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Joo</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persky</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudge</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzovetsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavletich</surname>
                    <given-names>NP</given-names>
                  </name>
                </person-group>
                <article-title>Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway.</article-title>
                <source>Science.</source>
                <year>2011</year>
                <volume>333</volume>
                <fpage>312</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21764741</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kahraman.2014.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahraman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyazyurek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yesilipek</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozturk</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ertem</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kansoy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksoylar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ku&#x0015f;konmaz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oniz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karakas</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tac</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulum</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekmekci</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <article-title>Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching.</article-title>
                <source>Reprod Biomed Online.</source>
                <year>2014</year>
                <volume>29</volume>
                <fpage>340</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">25066893</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kee.2012.3799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kee</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Molecular pathogenesis and clinical management of Fanconi anemia.</article-title>
                <source>J Clin Invest.</source>
                <year>2012</year>
                <volume>122</volume>
                <fpage>3799</fpage>
                <lpage>806</lpage>
                <pub-id pub-id-type="pmid">23114602</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kim.2012.1393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <article-title>Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.</article-title>
                <source>Genes Dev.</source>
                <year>2012</year>
                <volume>26</volume>
                <fpage>1393</fpage>
                <lpage>408</lpage>
                <pub-id pub-id-type="pmid">22751496</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kim.2011.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desetty</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutations of the SLX4 gene in Fanconi anemia.</article-title>
                <source>Nat Genet.</source>
                <volume>43</volume>
                <fpage>142</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21240275</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.knipscheer.2009.1698">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knipscheer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000e4;schle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enoiu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;rer</surname>
                    <given-names>OD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.</article-title>
                <source>Science.</source>
                <volume>326</volume>
                <fpage>1698</fpage>
                <lpage>701</lpage>
                <pub-id pub-id-type="pmid">19965384</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kowal.2007.2047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kowal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurtan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuckert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellenberger</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex.</article-title>
                <source>J Biol Chem.</source>
                <volume>282</volume>
                <fpage>2047</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">17082180</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kratz.2010.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kratz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;pf</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaden</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sendoel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eberhard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lademann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannav&#x000f3;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sartori</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hengartner</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiricny</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents.</article-title>
                <source>Cell.</source>
                <year>2010</year>
                <volume>142</volume>
                <fpage>77</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">20603016</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.kutler.2003.1249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kutler</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berwick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giampietro</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A 20-year perspective on the International Fanconi Anemia Registry (IFAR).</article-title>
                <source>Blood</source>
                <volume>101</volume>
                <fpage>1249</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">12393516</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.leung.2012.4491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fong</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2012</year>
                <volume>109</volume>
                <fpage>4491</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22396592</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.l_veill_.2004.39421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;veill&#x000e9;</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bier</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Laghmani el H, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, Patel KJ, Hoatlin ME, Joenje H, de Winter JP. The Fanconi anemia gene product FANCF is a flexible adaptor protein.</article-title>
                <source>J Biol Chem.</source>
                <year>2004</year>
                <volume>279</volume>
                <fpage>39421</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15262960</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.l_veill_.2006.556">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;veill&#x000e9;</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Laghmani el H, Rooimans MA, Bier P, Steltenpool J, Titus TA, Postlethwait JH, Hoatlin ME, Joenje H, de Winter JP. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC.</article-title>
                <source>DNA Repair (Amst)</source>
                <year>2006</year>
                <volume>5</volume>
                <fpage>556</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">16513431</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.levitus.2005.934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levitus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godthelp</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiegant</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elghalbzouri-Maghrani</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steltenpool</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arwert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zdzienicka</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiom</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.</article-title>
                <source>Nat Genet.</source>
                <volume>37</volume>
                <fpage>934</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16116423</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.levran.2005.931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levran</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attwooll</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milton</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velleuer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barral</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrini</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.</article-title>
                <source>Nat Genet.</source>
                <volume>37</volume>
                <fpage>931</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16116424</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.levran.1997.13051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levran</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magdalena</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verlander</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Sequence variation in the Fanconi anemia gene FAA.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>94</volume>
                <fpage>13051</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9371798</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.liang.2015.1947">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gygi</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>UHRF1 is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi anemia pathway.</article-title>
                <source>Cell Rep.</source>
                <year>2015</year>
                <volume>10</volume>
                <fpage>1947</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">25801034</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.ling.2007.2104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.</article-title>
                <source>EMBO J.</source>
                <volume>26</volume>
                <fpage>2104</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17396147</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.litman.2005.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Litman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.</article-title>
                <source>Cancer Cell.</source>
                <volume>8</volume>
                <fpage>255</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">16153896</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.lo_ten_foe.1996.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lo Ten Foe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosnoyan-Collins</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightfoot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carreau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callen</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strunk</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruyt</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arwert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchwald</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.</article-title>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>320</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8896563</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.lossaint.2013.678">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lossaint</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larroque</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeyre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bec</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larroque</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;caillet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gari</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantinou</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling.</article-title>
                <source>Mol Cell.</source>
                <year>2013</year>
                <volume>51</volume>
                <fpage>678</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">23993743</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mackay.2010.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacKay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;clais</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agostinho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deans</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacArtney</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gartner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helleday</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilley</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouse</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2.</article-title>
                <source>Cell.</source>
                <year>2010</year>
                <volume>142</volume>
                <fpage>65</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">20603015</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.macmillan.2015.3798">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeFor</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusenbery</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slungaard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierhut</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weisdorf</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Alternative donor hematopoietic cell transplantation for Fanconi anemia.</article-title>
                <source>Blood.</source>
                <year>2015</year>
                <volume>125</volume>
                <fpage>3798</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">25824692</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.macmillan.2010.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Haematopoeitic cell transplantation for Fanconi anaemia - when and how?</article-title>
                <source>Br J Haematol.</source>
                <volume>149</volume>
                <fpage>14</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">20136826</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.machida.2006.589">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Machida</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Machida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurtan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutta</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.</article-title>
                <source>Mol Cell.</source>
                <volume>23</volume>
                <fpage>589</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">16916645</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.magron.2015.e0140612">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elowe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carreau</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation.</article-title>
                <source>PLoS One.</source>
                <year>2015</year>
                <volume>10</volume>
                <fpage>e0140612</fpage>
                <pub-id pub-id-type="pmid">26466335</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.marsit.2004.1000">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marsit</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>KT</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.</article-title>
                <source>Oncogene</source>
                <volume>23</volume>
                <fpage>1000</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14647419</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.masserot.2008.3315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masserot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peffault de Latour</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocha</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigolet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soulier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.</article-title>
                <source>Cancer.</source>
                <year>2008</year>
                <volume>113</volume>
                <fpage>3315</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">18831513</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.matsushita.2005.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McHugh</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickson</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkitaraman</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurumizaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair.</article-title>
                <source>Mol Cell.</source>
                <volume>19</volume>
                <fpage>841</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16168378</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mccauley.2011.2370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCauley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGowan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaud</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holden</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <article-title>X-linked VACTERL with hydrocephalus syndrome: further delineation of the phenotype caused by FANCB mutations.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>2370</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">21910217</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.meetei.2003a.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallisch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Vrugt</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003a</year>
                <article-title>A novel ubiquitin ligase is deficient in Fanconi anemia.</article-title>
                <source>Nat Genet</source>
                <volume>35</volume>
                <fpage>165</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12973351</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.meetei.2004.1219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwaan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>X-linked inheritance of Fanconi anemia complementation group B.</article-title>
                <source>Nat Genet.</source>
                <volume>36</volume>
                <fpage>1219</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15502827</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.meetei.2005.958">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medhurst</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steltenpool</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dokal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.</article-title>
                <source>Nat Genet.</source>
                <volume>37</volume>
                <fpage>958</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16116422</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.meetei.2003b.3417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sechi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallisch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003b</year>
                <article-title>A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.</article-title>
                <source>Mol Cell Biol</source>
                <volume>23</volume>
                <fpage>3417</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">12724401</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mehta.2017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leemhuis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kernan</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prockop</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaradavou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Reilly</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guinan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulad</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Radiation-free, alternative donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.</article-title>
                <source>Blood.</source>
                <year>2017</year>
                <month>Feb</month>
                <day>8</day>
                <comment>doi[Epub ahead of print]</comment>
                <pub-id pub-id-type="doi">10.1182/blood-2016-09-743112</pub-id>
                <pub-id pub-id-type="pmid">28179273</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mehta.2010.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampkin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smolarek</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Numerical chromosomal changes and risk of development of myelodysplastic syndrome&#x02014;acute myeloid leukemia in patients with Fanconi anemia.</article-title>
                <source>Cancer Genet Cytogenet.</source>
                <volume>203</volume>
                <fpage>180</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21156231</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mehta.2007.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ileri</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smolarek</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Chemotherapy for Myeloid Malignancy in Children with Fanconi Anemia.</article-title>
                <source>Pediatr Blood Cancer</source>
                <year>2007</year>
                <volume>48</volume>
                <fpage>668</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16609946</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.meindl.2010.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellebrand</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erven</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wappenschmidt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niederacher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaal</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramser</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honisch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wichmann</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kast</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deissler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Myhsok</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiechle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmutzler</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.</article-title>
                <source>Nat Genet.</source>
                <volume>42</volume>
                <fpage>410</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20400964</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.mi.2004.8576">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiao</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>High</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroeder</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stukenberg</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shabanowitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>FANCG is phosphorylated at serines 383 and 387 during mitosis.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>24</volume>
                <fpage>8576</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15367677</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.montes_de_oca.2005.1003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Montes de Oca</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margossian</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houghtaling</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.</article-title>
                <source>Blood.</source>
                <volume>105</volume>
                <fpage>1003</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15454491</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.morgan.1999.1330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tipping</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>High frequency of large intragenic deletions in the Fanconi anemia group A gene.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>1330</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">10521298</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.morris.2011.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sikora</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayes</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganly</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.</article-title>
                <source>J Clin Oncol.</source>
                <year>2011</year>
                <volume>29</volume>
                <fpage>739</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">21189382</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.moynahan.2001.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moynahan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierce</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jasin</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>BRCA2 is required for homology-directed repair of chromosomal breaks.</article-title>
                <source>Mol Cell</source>
                <volume>7</volume>
                <fpage>263</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11239455</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.myers.2012.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spunt</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smolarek</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMasters</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2012</year>
                <volume>58</volume>
                <fpage>462</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21548014</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nabhan.2010.1783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nabhan</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitencourt</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duval</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abecasis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufour</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boudjedir</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocha</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passweg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanders</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snowden</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                  <collab>Aplastic Anaemia Working Party, EBMT</collab>
                </person-group>
                <article-title>Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients.</article-title>
                <source>Haematologica.</source>
                <year>2010</year>
                <volume>95</volume>
                <fpage>1783</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20494929</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nakanishi.2011.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakanishi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrouault</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovannangeli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moynahan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jasin</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication.</article-title>
                <source>Nat Struct Mol Biol.</source>
                <year>2011</year>
                <volume>18</volume>
                <fpage>500</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21423196</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nakanishi.2002.913">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakanishi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranganathan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>New</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stotsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kastan</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Interaction of FANCD2 and NBS1 in the DNA damage response.</article-title>
                <source>Nat Cell Biol</source>
                <volume>4</volume>
                <fpage>913</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12447395</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.narayan.2004.2994">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narayan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias-Pulido</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nandula</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basso</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugirtharaj</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansukhani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villella</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gissmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rst</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pothuri</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murty</surname>
                    <given-names>VV</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.</article-title>
                <source>Cancer Res.</source>
                <volume>64</volume>
                <fpage>2994</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15126331</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.neitzel.2007">
              <mixed-citation publication-type="book">Neitzel H, K&#x000fc;hl JS, Gerlach A, Ebell W, T&#x000f6;nnies H. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: results and implications. In: Schindler D, Hoehn H, eds. <italic toggle="yes">Fanconi Anemia. a Paradigmatic Disease for the Understanding of Cancer and Aging</italic>. Monographs in Human Genetics. Vol 15. Basel: Karger. 2007:79-94</mixed-citation>
            </ref>
            <ref id="fa.REF.neveling.2009.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoehn</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Genotype&#x02013;phenotype correlations in Fanconi anemia.</article-title>
                <source>Mutat Res</source>
                <volume>668</volume>
                <fpage>73</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19464302</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nicchia.2015.1003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicchia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benedicenti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Rocco</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottega</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inzana</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faleschini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappelli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mogni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanzial</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svahn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufour</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoia</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Clinical aspects of Fanconi anemia individuals with the same mutation of FANCF identified by next generation sequencing.</article-title>
                <source>Birth Defects Res A Clin Mol Teratol.</source>
                <year>2015</year>
                <volume>103</volume>
                <fpage>1003</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">26033879</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nijman.2005.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nijman</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dirac</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brummelkamp</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerkhoven</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernards</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.</article-title>
                <source>Mol Cell.</source>
                <volume>17</volume>
                <fpage>331</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15694335</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.nookala.2007.1638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nookala</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Insights into Fanconi Anaemia from the structure of human FANCE.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>35</volume>
                <fpage>1638</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">17308347</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.oda.2007.5016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyaso</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Hsp90 regulates the Fanconi anemia DNA damage response pathway.</article-title>
                <source>Blood</source>
                <volume>109</volume>
                <fpage>5016</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">17327415</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.oestergaard.2007.798">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oestergaard</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langevin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuiken</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pace</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedzwiedz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohzeki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sale</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Deubiquitination of FANCD2 is required for DNA crosslink repair.</article-title>
                <source>Mol Cell.</source>
                <volume>28</volume>
                <fpage>798</fpage>
                <lpage>809</lpage>
                <pub-id pub-id-type="pmid">18082605</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.olopade.2003.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olopade</surname>
                    <given-names>OI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>FANCF methylation contributes to chemoselectivity in ovarian cancer.</article-title>
                <source>Cancer Cell</source>
                <volume>3</volume>
                <fpage>417</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12781358</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.osorio.2013.1615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogliolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barroso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Hoya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cald&#x000e9;s</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000f3;n y Cajal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santamari&#x000f1;a</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vega</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quiles</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e1;zaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;ez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Sarmiento</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dur&#x000e1;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piqueras</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mar&#x000ed;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surrall&#x000e9;s</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben&#x000ed;tez</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles.</article-title>
                <source>Hum Mutat.</source>
                <year>2013</year>
                <volume>34</volume>
                <fpage>1615</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24027083</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.pace.2002.3414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pace</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosedale</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoatlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gergely</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>FANCE: the link between Fanconi anaemia complex assembly and activity.</article-title>
                <source>EMBO J.</source>
                <volume>21</volume>
                <fpage>3414</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">12093742</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.pang.2000.4724">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagerlie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christianson</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeble</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faulkner</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rathbun</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagby</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>20</volume>
                <fpage>4724</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">10848598</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.park.2016.672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virts</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Othman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraborty</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <article-title>Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene.</article-title>
                <source>J Med Genet.</source>
                <year>2016</year>
                <volume>53</volume>
                <fpage>672</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">27208205</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.parmar.2010.1186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parmar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykes</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuckert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deloach</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutok</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilliland</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'andrea</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.</article-title>
                <source>Stem Cells.</source>
                <volume>28</volume>
                <fpage>1186</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">20506303</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.pichierri.2004.1178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pichierri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosselli</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.</article-title>
                <source>EMBO J.</source>
                <volume>23</volume>
                <fpage>1178</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">14988723</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.polito.2014.7003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polito</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cukras</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spence</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kee</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.</article-title>
                <source>J Biol Chem.</source>
                <year>2014</year>
                <volume>289</volume>
                <fpage>7003</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">24451376</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.qiao.2004.46035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qiao</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bucheimer</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.</article-title>
                <source>J Biol Chem.</source>
                <volume>279</volume>
                <fpage>46035</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">15299017</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rafnar.2011.1104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rafnar</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gudbjartsson</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulem</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonasdottir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigurdsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonasdottir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besenbacher</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacey</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gudmundsson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnusson</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>le Roux</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlygsdottir</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helgadottir</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannsdottir</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gylfason</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tryggvadottir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonasson</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Juan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramon-Cajal</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Prats</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayordomo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panadero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aben</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Altena</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massuger</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aavikko</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kujala</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staff</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olafsdottir</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvarsdottir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saemundsson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olafsson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benediktsdottir</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulcher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiemeney</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayordomo</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorsteinsdottir</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in BRIP1 confer high risk of ovarian cancer.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>1104</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21964575</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rahman.2007.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renwick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barfoot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chagtai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayatilake</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.</article-title>
                <source>Nat Genet.</source>
                <year>2007</year>
                <volume>39</volume>
                <fpage>165</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17200668</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rajendra.2014.858">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajendra</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oestergaard</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langevin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dornan</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passmore</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>The genetic and biochemical basis of FANCD2 monoubiquitination.</article-title>
                <source>Mol Cell.</source>
                <year>2014</year>
                <volume>54</volume>
                <fpage>858</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">24905007</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.reid.2007.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wurm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yetgin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.</article-title>
                <source>Nat Genet</source>
                <volume>39</volume>
                <fpage>162</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17200671</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rickman.2015.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rickman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abhyankar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donovan</surname>
                    <given-names>FX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanborn</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sougnez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elemento</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandrasekharappa</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia.</article-title>
                <source>Cell Rep.</source>
                <year>2015</year>
                <volume>12</volume>
                <fpage>35</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">26119737</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rose.2014.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korbee</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas Ris</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyal</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherafat-Kazemzadeh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bollepalli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeng</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FO</given-names>
                  </name>
                </person-group>
                <article-title>Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2014</year>
                <volume>61</volume>
                <fpage>11</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24019220</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rosenberg.2008.511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebell</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.</article-title>
                <source>Haematologica.</source>
                <volume>93</volume>
                <fpage>511</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18322251</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rosenberg.2005.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants.</article-title>
                <source>Blood.</source>
                <volume>105</volume>
                <fpage>67</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">15331448</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.rosenberg.2011.1877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamary</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <article-title>How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>1877</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">21739583</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.sarkies.2012.1485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarkies</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balasubramanian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sale</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA.</article-title>
                <source>Nucleic Acids Res.</source>
                <year>2012</year>
                <volume>40</volume>
                <fpage>1485</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">22021381</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.sato.2012.4553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurumizaka</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>DNA robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI.</article-title>
                <source>Nucleic Acids Res.</source>
                <year>2012</year>
                <volume>40</volume>
                <fpage>4553</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">22287633</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.sawyer.2015.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e4;hk&#x000f6;nen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kircher</surname>
                    <given-names>M</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.</article-title>
                <source>Cancer Discov.</source>
                <year>2015</year>
                <volume>5</volume>
                <fpage>135</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">25472942</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.scheckenbach.2012.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheckenbach</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filger-Brillinger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strimling</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheurlen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Treatment of the bone marrow failure in Fanconi anemia patients with danazol.</article-title>
                <source>Blood Cells Mol Dis.</source>
                <volume>48</volume>
                <fpage>128</fpage>
                <lpage>131</lpage>
                <pub-id pub-id-type="pmid">22178060</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.seal.2006.1239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renwick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barfoot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chagtai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayatilake</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuffog</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.</article-title>
                <source>Nat Genet.</source>
                <year>2006</year>
                <volume>38</volume>
                <fpage>1239</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17033622</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.shimamura.2010.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Pathophysiology and management of inherited bone marrow failure syndromes.</article-title>
                <source>Blood Rev.</source>
                <volume>24</volume>
                <fpage>101</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">20417588</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.singh.2009.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agarwal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grassman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godthelp</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahengbam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steltenpool</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meetei</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.</article-title>
                <source>Blood.</source>
                <volume>114</volume>
                <fpage>174</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">19423727</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.smogorzewska.2010.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desetty</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlabach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowa</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colai&#x000e1;covo</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.</article-title>
                <source>Mol Cell.</source>
                <year>2010</year>
                <volume>39</volume>
                <fpage>36</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">20603073</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.smogorzewska.2007.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuoka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinciguerra</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>ER</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Hurov</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballif</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gygi</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elledge</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.</article-title>
                <source>Cell.</source>
                <volume>129</volume>
                <fpage>289</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">17412408</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.sommers.2014.19928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sommers</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinds</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wold</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lei</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosh</surname>
                    <given-names>RM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Novel function of the Fanconi anemia group J or RECQ1 helicase to disrupt protein-DNA complexes in a replication protein A-stimulated manner.</article-title>
                <source>J Biol Chem.</source>
                <year>2014</year>
                <volume>289</volume>
                <fpage>19928</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">24895130</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.song.2010.31525">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>IY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurkar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaziri</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway.</article-title>
                <source>J Biol Chem.</source>
                <volume>285</volume>
                <fpage>31525</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">20675655</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.spanier.2012.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spanier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koelbl</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichert</surname>
                    <given-names>TE</given-names>
                  </name>
                </person-group>
                <article-title>Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.</article-title>
                <source>J Craniomaxillofac Surg.</source>
                <year>2012</year>
                <volume>40</volume>
                <fpage>510</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21925890</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.stoepker.2011.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoepker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuster</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilhorst-Hofstee</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steltenpool</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eirich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korthof</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieuwint</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettecken</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.</article-title>
                <source>Nat Genet.</source>
                <volume>43</volume>
                <fpage>138</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">21240277</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.talbot.2014.e199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peffault de Latour</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raffoux</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchbinder</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigouroux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milpied</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soulier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michallet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soci&#x000e9;</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.</article-title>
                <source>Haematologica.</source>
                <year>2014</year>
                <volume>99</volume>
                <fpage>e199</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">25085358</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.tamary.2010.1300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamary</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishri</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yacobovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zilber</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dgany</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aviner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stepensky</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravel-Vilk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplinsky</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Barak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elhasid</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapelusnik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attias</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaniv</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.</article-title>
                <source>Haematologica.</source>
                <volume>95</volume>
                <fpage>1300</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20435624</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.tan.2011.e591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cutcutache</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zang</surname>
                    <given-names>ZJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iqbal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.</article-title>
                <source>J Clin Oncol.</source>
                <year>2011</year>
                <volume>29</volume>
                <fpage>e591</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21519011</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.taniguchi.2006.4223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Molecular pathogenesis of Fanconi anemia: recent progress.</article-title>
                <source>Blood</source>
                <volume>107</volume>
                <fpage>4223</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">16493006</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.taniguchi.2002a.2414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Higuera</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.</article-title>
                <source>Blood</source>
                <volume>100</volume>
                <fpage>2414</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12239151</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.taniguchi.2002b.459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Higuera</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kastan</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Convergence of the Fanconi anemia and ataxia-telangiectasia signaling pathways.</article-title>
                <source>Cell</source>
                <volume>109</volume>
                <fpage>459</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12086603</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.taniguchi.2003.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ameziane</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mok</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.</article-title>
                <source>Nat Med.</source>
                <volume>9</volume>
                <fpage>568</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">12692539</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.tischkowitz.2007.6788">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabbaghian</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis-Filho</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beers</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quenneville</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omeroglu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepage</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nederlof</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>WD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Analysis of PALB2/FANCN-associated breast cancer families.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>104</volume>
                <fpage>6788</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">17420451</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.tolar.2011.1193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adair</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoniou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholomae</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueren</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavazzana-Calvo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clapp</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalgleish</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Von Kalle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiem</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindeman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naldini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renella</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoeyen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrasher</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.</article-title>
                <source>Mol Ther.</source>
                <year>2011</year>
                <volume>19</volume>
                <fpage>1193</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21540837</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.turner.2004.814">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tutt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hallmarks of 'BRCAness' in sporadic cancers.</article-title>
                <source>Nat Rev Cancer</source>
                <volume>4</volume>
                <fpage>814</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15510162</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.uma_a.2011.3071">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uma&#x000f1;a</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magoulas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacino</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>A male newborn with VACTERL association and Fanconi anemia with a FANCB deletion detected by array comparative genomic hybridization (aCGH).</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>3071</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22052692</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.van_der_heijden.2003.2585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Heijden</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeo</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruban</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Fanconi anemia gene mutations in young-onset pancreatic cancer.</article-title>
                <source>Cancer Res.</source>
                <year>2003</year>
                <volume>63</volume>
                <fpage>2585</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12750283</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.vandenberg.2003.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vandenberg</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gergely</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pace</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallery</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiom</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>BRCA1-independent ubiquitination of FANCD2.</article-title>
                <source>Mol Cell.</source>
                <volume>12</volume>
                <fpage>247</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">12887909</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.vaz.2010.406">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuster</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erven</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kesterton</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autore</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraternali</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimwade</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaal</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutation of the RAD51C gene in a Fanconi anemia-like disorder.</article-title>
                <source>Nat Genet.</source>
                <volume>42</volume>
                <fpage>406</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20400963</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.vetro.2015.562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vetro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iascone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limongelli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ameziane</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gana</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Mina</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giussani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzuti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalatta</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Loss-of-function FANCL mutations associate with severe Fanconi anemia overlapping the VACTERL association.</article-title>
                <source>Hum Mutat.</source>
                <year>2015</year>
                <volume>36</volume>
                <fpage>562</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25754594</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.virts.2015.5093">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Virts</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaas</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelich</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lottmann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchal</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharf</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufour</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanciotti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farruggia</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savasan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheckenbach</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagenmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leffak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honisch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niederacher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraborty</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timms</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanchbury</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpi</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2015</year>
                <volume>24</volume>
                <fpage>5093</fpage>
                <lpage>108</lpage>
                <pub-id pub-id-type="pmid">26085575</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wagner.2004.3226">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levran</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deffenbaugh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satagopan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Porat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mah</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutler</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>3226</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15070707</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wang.2015.354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>SnapShot: Fanconi anemia and associated proteins.</article-title>
                <source>Cell.</source>
                <year>2015</year>
                <volume>160</volume>
                <fpage>354</fpage>
                <lpage>354.e1</lpage>
                <pub-id pub-id-type="pmid">25594185</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wang.2004.5850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.</article-title>
                <source>Mol Cell Biol</source>
                <volume>24</volume>
                <fpage>5850</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15199141</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wang.2007.3098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuckert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellenberger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>27</volume>
                <fpage>3098</fpage>
                <lpage>108</lpage>
                <pub-id pub-id-type="pmid">17296736</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wang.2006.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.</article-title>
                <source>Cancer Biol Ther</source>
                <volume>5</volume>
                <fpage>256</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">16418574</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wang.2015.478">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lach</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molina</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanborn</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierhut</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornes</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abhyankar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sougnez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowalczykowski</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smogorzewska</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.</article-title>
                <source>Mol Cell.</source>
                <year>2015</year>
                <volume>59</volume>
                <fpage>478</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">26253028</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.whitney.1993.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitney</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moses</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.</article-title>
                <source>Nat Genet</source>
                <volume>4</volume>
                <fpage>202</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8348157</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wijker.1999.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wijker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herterich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tipping</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dokal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavenagh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Weel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samochatova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karwacki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bekassy</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abecasis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebell</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwee</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ravel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>7</volume>
                <fpage>52</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10094191</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.williams.2011a.5078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longerich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaziri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI.</article-title>
                <source>Blood.</source>
                <year>2011a</year>
                <volume>117</volume>
                <fpage>5078</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">21355096</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.williams.2011b.4395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitson-Salazar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomashevski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ananth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glazer</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semmes</surname>
                    <given-names>OJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Functional and physical interaction between the mismatch repair and FA-BRCA pathways.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2011b</year>
                <volume>20</volume>
                <fpage>4395</fpage>
                <lpage>410</lpage>
                <pub-id pub-id-type="pmid">21865299</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wilson.2010.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.</article-title>
                <source>Mutat Res.</source>
                <volume>689</volume>
                <fpage>12</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">20450923</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wong.2003.2063">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKerlie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyn</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchwald</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>2063</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">12913077</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wu.2009.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosh</surname>
                    <given-names>RM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.</article-title>
                <source>Curr Mol Med.</source>
                <volume>9</volume>
                <fpage>470</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">19519404</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.wu.2012.21699">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommers</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loiland</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kisker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosh</surname>
                    <given-names>RM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>The Q motif of Fanconi anemia group J protein (FANCJ) DNA helicase regulates its dimerization, DNA binding, and DNA repair function.</article-title>
                <source>J Biol Chem.</source>
                <year>2012</year>
                <volume>287</volume>
                <fpage>21699</fpage>
                <lpage>716</lpage>
                <pub-id pub-id-type="pmid">22582397</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.xia.2007.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsman</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ameziane</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooimans</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errami</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llera</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.</article-title>
                <source>Nat Genet.</source>
                <volume>39</volume>
                <fpage>159</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">17200672</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.xia.2006.719">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakanishi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohashi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christ</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jasin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couch</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.</article-title>
                <source>Mol Cell.</source>
                <volume>22</volume>
                <fpage>719</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">16793542</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.xie.2012.e1002786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillemette</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniatis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatesh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosh</surname>
                    <given-names>RM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response.</article-title>
                <source>PLoS Genet.</source>
                <year>2012</year>
                <volume>8</volume>
                <fpage>e1002786</fpage>
                <pub-id pub-id-type="pmid">22792074</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.yamashita.1994.6712">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>The Fanconi anemia polypeptide FACC is localized to the cytoplasm.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>91</volume>
                <fpage>6712</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7517562</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.yamashita.1996.4424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corless</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joenje</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The Clinical variability of Fanconi Anemia (Type C) results from expression of an amino terminal truncated FAC polypeptide with partial activity.</article-title>
                <source>Blood</source>
                <volume>87</volume>
                <fpage>4424</fpage>
                <pub-id pub-id-type="pmid">8639804</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.yoshikiyo.2010.21553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoshikiyo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kratz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirota</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishihara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurumizaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiricny</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2010</year>
                <volume>107</volume>
                <fpage>21553</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21115814</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zhang.2010.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auerbach</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.</article-title>
                <source>Chromosoma.</source>
                <volume>119</volume>
                <fpage>637</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">20676667</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zhi.2009.8775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupfer</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for Fanconi anemia pathway function and BRCA2 interaction.</article-title>
                <source>Cancer Res.</source>
                <volume>69</volume>
                <fpage>8775</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">19861535</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zhu.2015a.2867">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shao</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks.</article-title>
                <source>Oncogene.</source>
                <year>2015a</year>
                <volume>34</volume>
                <fpage>2867</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">25132264</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zhu.2015b.1809">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaithamby</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>FANCD2 influences replication fork processes and genome stability in response to clustered DSBs.</article-title>
                <source>Cell Cycle.</source>
                <year>2015b</year>
                <volume>14</volume>
                <fpage>1809</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">26083937</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zou.2013.1022">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickner</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezvani</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.</article-title>
                <source>Biol Open.</source>
                <year>2013</year>
                <volume>2</volume>
                <fpage>1022</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24167712</pub-id>
              </element-citation>
            </ref>
            <ref id="fa.REF.zou.2014.3685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.</article-title>
                <source>Cell Cycle.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>3685</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">25483079</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="fa.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="fa.Suggested_Reading.reflist0">
            <ref id="fa.REF.auerbach">
              <mixed-citation publication-type="book">Auerbach AD, Buchwald M, Joenje H. Fanconi anemia. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> New York, NY: McGraw-Hill. Chap 31. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="fa.REF.huret.2002">
              <mixed-citation publication-type="web">Huret JL. Fanconi anaemia. <italic toggle="yes">Atlas of Genetics and Cytogenetics Oncology and Haematology</italic>. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://atlasgeneticsoncology.org/">online</ext-link>. 2002. Accessed 3-21-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="fa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="fa.Author_Notes">
          <title>Author Notes</title>
          <p><bold>Comprehensive Center for Fanconi Anemia</bold>Dana Farber Cancer Institute Mayer 676 44 Binney Street Boston, MA 02115 Phone: 617-632-6302</p>
        </sec>
        <sec id="fa.Author_History">
          <title>Author History</title>
          <p>Blanche P Alter, MD, MPH, FAAP; National Cancer Institute (2011-2016)Alan D'Andrea, MD; Dana Farber Cancer Institute (2002-2007) Gary Kupfer, MD; Yale University School of Medicine (2011-2016)Parinda A Mehta, MD (2016-present)Lisa Moreau, MS; Dana Farber Cancer Institute (2002-2007) Akiko Shimamura, MD, PhD; Dana Farber Cancer Institute (2002-2007) Toshiyasu Taniguchi, MD, PhD; Fred Hutchinson Cancer Research Center (2007-2011)Jakub Tolar, MD, PhD (2016-present)</p>
        </sec>
        <sec id="fa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>23 February 2017 (aa; pm) Revision: addition of two genes: <italic toggle="yes">MAD2L2</italic> and <italic toggle="yes">XRCC2</italic>; edits to <xref ref-type="sec" rid="fa.Prevention_of_Secondary_Complications">Prevention of Secondary Complications</xref></p>
            </list-item>
            <list-item>
              <p>22 September 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 February 2013 (cd) Revision: deletion/duplication analysis available clinically for <italic toggle="yes">FANCC</italic></p>
            </list-item>
            <list-item>
              <p>6 September 2012 (cd) Revision: sequence analysis for mutations in <italic toggle="yes">RAD51C</italic> and <italic toggle="yes">SLX4</italic> available clinically</p>
            </list-item>
            <list-item>
              <p>3 November 2011 (cd) Revision: deletion/duplication analysis available clinically for <italic toggle="yes">PALB2</italic> deletions</p>
            </list-item>
            <list-item>
              <p>10 February 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 March 2008 (cd) Revision: sequence analysis and prenatal testing available clinically for <italic toggle="yes">FANCB-</italic>, <italic toggle="yes">FANCE</italic>-, <italic toggle="yes">FANCF</italic>- and <italic toggle="yes">FANCI</italic>-related Fanconi anemia</p>
            </list-item>
            <list-item>
              <p>29 January 2008 (cd) Revision: sequence analysis of entire coding region of <italic toggle="yes">FANCG</italic> and prenatal testing available</p>
            </list-item>
            <list-item>
              <p>7 November 2007 (cd) Revision: molecular genetic testing and prenatal diagnosis no longer available on a clinical basis for <italic toggle="yes">FANCF</italic> and <italic toggle="yes">FANCG</italic></p>
            </list-item>
            <list-item>
              <p>22 June 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1 March 2006 (cd) Revision: <italic toggle="yes">FANCB</italic> mutations: X-linked inheritance</p>
            </list-item>
            <list-item>
              <p>3 January 2006 (as) Revision: deletion/duplication testing clinically available</p>
            </list-item>
            <list-item>
              <p>13 September 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 February 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>31 May 2001 (as) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
